"molregno","standard_relation","standard_type","standard_value","standard_units","tid","assay_type","assay_test_type","assay_category","description","assay_tax_id","assay_strain","assay_tissue","assay_cell_type","assay_subcellular_fraction","relationship_type","assay_id"
18694,"=","IC50",1000,"nM",126,"B",NA,NA,"In vitro potency against human Prostaglandin G/H synthase 2 in the human whole blood assay.",NA,NA,NA,NA,NA,"H",43840
18694,"=","IC50",21,"nM",15,"B",NA,NA,"Inhibitory activity against human carbonic anhydrase II was determined",NA,NA,NA,NA,NA,"H",44892
18694,"=","IC50",290,"nM",11035,"B",NA,NA,"Inhibitory activity against bovine carbonic anhydrase IV was determined",NA,NA,NA,NA,NA,"H",45257
18694,"=","IC50",16,"nM",12952,"B",NA,NA,"Inhibitory activity against human carbonic anhydrase IX was determined",NA,NA,NA,NA,NA,"H",45437
18694,"=","IC50",50000,"nM",10193,"B",NA,NA,"Inhibitory activity against human carbonic anhydrase I was determined",NA,NA,NA,NA,NA,"H",47489
23466,"=","IC50",2,"nM",13000,"B",NA,NA,"Inhibition of human recombinant interstitial collagenase MMP-1 at 100 uM",9606,NA,NA,NA,NA,"D",49503
23466,"=","Ki",2,"nM",13000,"B",NA,NA,"Evaluated for inhibitory activity against Human fibroblast collagenase (HFC)",NA,NA,NA,NA,NA,"H",49511
18694,"=","IC50",50,"nM",96,"B",NA,NA,"In vitro inhibitory potency against U-937 microsomal COX-1",NA,NA,NA,NA,NA,"H",51682
18694,"=","IC50",6300,"nM",96,"B",NA,NA,"In vitro inhibitory potency against human COX-1 (HWB COX-2) by whole blood assay",NA,NA,NA,NA,NA,"H",51684
18694,"=","IC50",50,"nM",96,"B",NA,NA,"Inhibition of COX-1 in U-937 (human lymphoma) cell microsomes.",NA,NA,NA,NA,"Microsomes","H",51691
18694,"=","IC50",1000,"nM",126,"B",NA,NA,"In vitro inhibitory potency against human COX-2 (HWB COX-2) by whole blood assay",NA,NA,NA,NA,NA,"H",51705
18694,"=","IC50",1000,"nM",126,"B",NA,NA,"Inhibitory potency against PGE-2 production in the human whole blood (HWB COX-2) assay",NA,NA,"Blood",NA,NA,"H",51857
87221,"=","IC50",100,"nM",9,"B",NA,NA,"In vitro inhibition of HER1 autophosphorylation.",NA,NA,NA,NA,NA,"H",63608
87221,"=","IC50",13500,"nM",188,"B",NA,NA,"In vitro inhibition of ERBB2 receptor kinase autophosphorylation.",NA,NA,NA,NA,NA,"H",65257
87221,"=","IC50",13500,"nM",188,"B",NA,NA,"Inhibition of ERBB2 receptor autophosphorylation",NA,NA,NA,NA,NA,"H",65265
87221,"=","IC50",501.19,"nM",9,"B",NA,NA,"Inhibitory activity against epidermal growth factor receptor (EGFR)",NA,NA,NA,NA,NA,"H",66876
87221,"=","IC50",100,"nM",9,"B",NA,NA,"Inhibition of Epidermal growth factor receptor autophosphorylation",NA,NA,NA,NA,NA,"H",67055
442943,"=","IC50",5000,"nM",12179,"B",NA,NA,"Inhibition of GST-Grb2 Tyrosine kinase SH2 domain binding to [3H]labeled-phosphopeptide (Ac-SpYVNK-NH-C(O)-CH2CH2H3)",NA,NA,NA,NA,NA,"H",70494
23466,"=","IC50",0.2,"nM",12592,"B",NA,NA,"Inhibition of human recombinant 92 kDa gelatinase MMP-9 at 100 uM",9606,NA,NA,NA,NA,"D",71646
442943,"=","IC50",5000,"nM",10110,"B",NA,NA,"In vitro binding assay of Shc-derived phosphopeptide to Growth factor receptor bound protein 2 SH2 in B104-1-1 cells was determined",NA,NA,NA,NA,NA,"H",72352
17224,"=","IC50",530,"nM",191,"B",NA,NA,"Compound was tested for inhibitory activity against HIV-1 protease",NA,NA,NA,NA,NA,"H",79805
87221,"=","IC50",79432823472428.2,"nM",10849,"B",NA,NA,"In vitro inhibition of Janus kinase 3.",NA,NA,NA,NA,NA,"H",91954
23466,"=","Ki",2,"nM",13000,"B",NA,NA,"Inhibition of human fibroblast collagenase, matrix metalloprotease-1",9606,NA,NA,NA,NA,"D",101763
23466,"=","Ki",46,"nM",11109,"B",NA,NA,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",9606,NA,NA,NA,NA,"D",102092
23466,"=","IC50",0.4,"nM",13001,"B",NA,NA,"Inhibition of Matrix metalloprotease-2",9606,NA,NA,NA,NA,"D",104364
23466,"=","IC50",0.104,"nM",13001,"B",NA,NA,"Inhibition of human matrix metalloprotease-2",9606,NA,NA,NA,NA,"D",104382
23466,"=","Ki",0.57,"nM",13001,"B",NA,NA,"Inhibition of Matrix metalloprotease-2",9606,NA,NA,NA,NA,"D",104398
23466,"=","Ki",0.39,"nM",13001,"B",NA,NA,"Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2)",NA,NA,NA,NA,NA,"H",104542
113416,"=","Ki",1800,"nM",13001,"B",NA,NA,"Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2)",NA,NA,NA,NA,NA,"H",104542
112889,"=","Ki",300,"nM",13001,"B",NA,NA,"Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2)",NA,NA,NA,NA,NA,"H",104542
23466,"=","IC50",7,"nM",13001,"B",NA,NA,"Inhibition of matrix metalloprotease-2 (MMP-2)",NA,NA,NA,NA,NA,"H",104556
23466,"=","IC50",17,"nM",10226,"B",NA,NA,"Inhibition of matrix metalloprotease-26 (MMP-26)",NA,NA,NA,NA,NA,"H",104566
23466,"=","IC50",1.9,"nM",11109,"B",NA,NA,"Activity against Matrix metalloprotease-3 (MMP-3).",NA,NA,NA,NA,NA,"H",104576
23466,"=","IC50",0.191,"nM",11109,"B",NA,NA,"Inhibition of human matrix metalloprotease-3",9606,NA,NA,NA,NA,"D",104721
23466,"=","Ki",26,"nM",11109,"B",NA,NA,"Inhibition of Matrix metalloprotease-3",9606,NA,NA,NA,NA,"D",104739
23466,"<","Ki",1,"nM",11110,"B",NA,NA,"Inhibition of human Matrix metalloprotease-8",9606,NA,NA,NA,NA,"D",105200
113416,"=","Ki",390,"nM",11110,"B",NA,NA,"The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8)",NA,NA,NA,NA,NA,"H",105205
112889,"=","Ki",54,"nM",11110,"B",NA,NA,"The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8)",NA,NA,NA,NA,NA,"H",105205
23466,"=","Ki",0.18,"nM",11110,"B",NA,NA,"The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8)",NA,NA,NA,NA,NA,"H",105205
23466,"=","IC50",0.5,"nM",12592,"B",NA,NA,"Activity against Matrix metalloprotease-9 (MMP-9).",NA,NA,NA,NA,NA,"H",105225
23466,"=","Ki",0.69,"nM",12592,"B",NA,NA,"Inhibition of human Matrix metalloprotease-9",9606,NA,NA,NA,NA,"D",105391
113416,"=","Ki",4500,"nM",12592,"B",NA,NA,"The compound was tested for its binding affinity towards 92 kDa gelatinase (Matrix metalloprotease-9)",NA,NA,NA,NA,NA,"H",105401
112889,"=","Ki",270,"nM",12592,"B",NA,NA,"The compound was tested for its binding affinity towards 92 kDa gelatinase (Matrix metalloprotease-9)",NA,NA,NA,NA,NA,"H",105401
23466,"=","Ki",0.57,"nM",12592,"B",NA,NA,"The compound was tested for its binding affinity towards 92 kDa gelatinase (Matrix metalloprotease-9)",NA,NA,NA,NA,NA,"H",105401
23466,"=","IC50",15,"nM",12592,"B",NA,NA,"Inhibition of matrix metalloprotease-9 (MMP-9)",NA,NA,NA,NA,NA,"H",105527
23466,"=","IC50",1.5,"nM",13000,"B",NA,NA,"Activity against Matrix metalloprotease-1 (MMP-1).",NA,NA,NA,NA,NA,"H",105950
23466,"=","IC50",3,"nM",13000,"B",NA,NA,"Inhibition of matrix metalloprotease-1",9606,NA,NA,NA,NA,"D",105956
23466,"=","IC50",6,"nM",13000,"B",NA,NA,"Inhibition of matrix metalloprotease-1 (MMP-1)",NA,NA,NA,NA,NA,"H",106301
23466,"=","IC50",13,"nM",11871,"B",NA,NA,"Inhibition of matrix metalloprotease-12 (MMP-12)",NA,NA,NA,NA,NA,"H",106462
23466,"=","IC50",23,"nM",11154,"B",NA,NA,"Inhibition of matrix metalloprotease-14 (MMP-14)",NA,NA,NA,NA,NA,"H",106791
23466,"=","IC50",6,"nM",11043,"B",NA,NA,"Inhibition of matrix metalloprotease-15 (MMP-15)",NA,NA,NA,NA,NA,"H",106795
23466,"=","IC50",8,"nM",11044,"B",NA,NA,"Inhibition of matrix metalloprotease-16 (MMP-16)",NA,NA,NA,NA,NA,"H",106799
23466,"=","IC50",1.1,"nM",13001,"B",NA,NA,"Activity against Matrix metalloprotease-2 (MMP-2).",NA,NA,NA,NA,NA,"H",106804
32530,"=","IC50",15625,"nM",105018,"B",NA,NA,"Inhibition of phosphorylase kinase (PhK)",NA,NA,NA,NA,NA,"H",156517
17224,"=","Ki",0.01,"nM",191,"B",NA,NA,"Inhibition of HIV protease",11676,NA,NA,NA,NA,"D",157559
18694,"=","IC50",39.81,"nM",126,"B",NA,NA,"Inhibition of human Prostaglandin G/H synthase 2",NA,NA,NA,NA,NA,"H",157693
17224,"=","Ki",0.54,"nM",191,"B",NA,NA,"Inhibition constant against HIV-1 Protease",11676,NA,NA,NA,NA,"D",157714
17224,"=","Ki",0.23,"nM",191,"B",NA,NA,"Inhibitory concentration against HIV-1 protease",11676,NA,NA,NA,NA,"D",157740
18694,"=","IC50",0.7,"nM",10575,"B",NA,NA,"Tested for inhibition against Prostaglandin G/H synthase 2 from mouse resident macrophages",NA,NA,NA,NA,NA,"H",157820
18694,"=","IC50",39.81,"nM",11112,"B",NA,NA,"Inhibitory activity against prostaglandin G/H synthase 2 (COX-2)",NA,NA,NA,NA,NA,"H",157854
18694,"=","IC50",1100,"nM",13031,"B",NA,NA,"In vitro inhibitory concentration against rat Prostaglandin G/H synthase 2",NA,NA,NA,NA,NA,"H",157858
18694,"=","IC50",56.7,"nM",17100,"B",NA,NA,"In vitro inhibition against ovine Prostaglandin G/H synthase 2",9940,NA,NA,NA,NA,"D",157989
18694,"=","IC50",57,"nM",11111,"B",NA,NA,"In vitro inhibitory activity against prostaglandin G/H synthase 2 (COX-2)",NA,NA,NA,NA,NA,"H",157990
18694,"=","IC50",57,"nM",17100,"B",NA,NA,"In vitro inhibitory activity against prostaglandin G/H synthase 2 from ovine",9940,NA,NA,NA,NA,"D",157991
18694,"=","IC50",1200,"nM",126,"B",NA,NA,"Compound was tested for the inhibition of human Prostaglandin G/H synthase 2 (COX-2) in human whole blood",NA,NA,NA,NA,NA,"H",157999
18694,"=","IC50",50.7,"nM",126,"B",NA,NA,"Inhibitory concentration against Prostaglandin G/H synthase 2",NA,NA,NA,NA,NA,"H",158001
18694,"=","IC50",5570,"nM",11343,"B",NA,NA,"In vitro inhibitory activity against canine prostaglandin G/H synthase 1.",NA,NA,NA,NA,NA,"H",158583
18694,"=","IC50",9730,"nM",96,"B",NA,NA,"Biochemical index for Prostaglandin G/H synthase 1 measured as, thromboxane 2 (TXB2) levels following blood coagulation",NA,NA,NA,NA,NA,"H",158586
18694,"=","IC50",14000,"nM",96,"B",NA,NA,"Compound was evaluated for inhibition concentration of prostaglandin G/H synthase 1 in human blood",NA,NA,NA,NA,NA,"H",158590
18694,"=","IC50",15000,"nM",96,"B",NA,NA,"Inhibition of human Prostaglandin G/H synthase 1",9606,NA,NA,NA,NA,"D",158592
18694,"=","IC50",6300,"nM",96,"B",NA,NA,"In vitro potency against human Prostaglandin G/H synthase 1 (hCOX-1) in the human whole blood assay.",9606,NA,NA,NA,NA,"D",158595
18694,"=","IC50",50,"nM",96,"B",NA,NA,"In vitro potency against human Prostaglandin G/H synthase 1 in U937 microsomes. ",NA,NA,NA,NA,"Microsomes","H",158596
18694,"=","IC50",15000,"nM",96,"B",NA,NA,"In Vitro activity of compound against human recombinant Prostaglandin G/H synthase 1",NA,NA,NA,NA,NA,"H",158734
18694,"=","IC50",15000,"nM",96,"B",NA,NA,"In Vitro activity of compound against human recombinant Prostaglandin G/H synthase 1",NA,NA,NA,NA,NA,"H",158734
18694,"=","IC50",6300,"nM",96,"B",NA,NA,"In vitro inhibitory activity against human whole blood Prostaglandin G/H synthase 1",NA,NA,NA,NA,NA,"H",158743
18694,"=","IC50",10700,"nM",96,"B",NA,NA,"In vitro inhibitory activity against recombinant human Prostaglandin G/H synthase 1",NA,NA,NA,NA,NA,"H",158746
18694,"=","IC50",22900,"nM",96,"B",NA,NA,"In vitro inhibitory concentration of compound required to inhibit Prostaglandin G/H synthase 1 enzyme was determined",NA,NA,NA,NA,NA,"H",158750
18694,"=","IC50",15000,"nM",96,"B",NA,NA,"In vitro inhibitory concentration required to block recombinant human prostaglandin G/H synthase 1 (COX-1)",NA,NA,NA,NA,NA,"H",158753
18694,"=","IC50",22900,"nM",96,"B",NA,NA,"Inhibition of human Prostaglandin G/H synthase 1",NA,NA,NA,NA,NA,"H",158763
17224,"=","Ki",0.17,"nM",191,"B",NA,NA,"Inhibition of HIV-1 Protease activity",11676,NA,NA,NA,NA,"D",158784
18694,"=","IC50",14200,"nM",96,"B",NA,NA,"Inhibitory activity against prostaglandin G/H synthase 1",NA,NA,NA,NA,NA,"H",158914
18694,"=","IC50",6300,"nM",96,"B",NA,NA,"Inhibitory activity against Prostaglandin G/H synthase 1 in human whole blood",NA,NA,NA,NA,NA,"H",158916
18694,"=","IC50",27000,"nM",96,"B",NA,NA,"Inhibition of human Prostaglandin G/H synthase 1",9606,NA,NA,NA,NA,"D",158920
18694,"=","IC50",6300,"nM",96,"B",NA,NA,"Inhibitory concentration was measured against Prostaglandin G/H synthase 1 in human whole blood",NA,NA,NA,NA,NA,"H",158928
18694,"=","IC50",50,"nM",96,"B",NA,NA,"Inhibitory concentration was measured against Prostaglandin G/H synthase 1 in the sensitive U937 microsome assay",NA,NA,NA,NA,NA,"H",158929
17224,"=","Ki",2,"nM",191,"B",NA,NA,"Binding affinity against HIV-protease inhibitor.",12721,NA,NA,NA,NA,"H",159134
18694,"<","IC50",1e+05,"nM",96,"B",NA,NA,"Compound was tested for the inhibition of recombinant human Prostaglandin G/H synthase 1 (COX-1)",NA,NA,NA,NA,NA,"H",159255
18694,"=","IC50",9.3,"nM",11112,"B",NA,NA,"Tested for inhibition against Prostaglandin G/H synthase 1 from mouse resident macrophages",NA,NA,NA,NA,NA,"H",159265
18694,"=","IC50",14200,"nM",12478,"B",NA,NA,"In vitro inhibitory concentration against rat prostaglandin G/H synthase 1",NA,NA,NA,NA,NA,"H",159271
18694,"=","IC50",22900,"nM",17047,"B",NA,NA,"In vitro inhibition against ovine Prostaglandin G/H synthase 1",9940,NA,NA,NA,NA,"D",159277
18694,"=","IC50",22900,"nM",17047,"B",NA,NA,"In vitro inhibitory activity against Prostaglandin G/H synthase 1 (COX-1)",9940,NA,NA,NA,NA,"D",159278
18694,"=","IC50",10700,"nM",17047,"B",NA,NA,"In vitro inhibitory activity against prostaglandin G/H synthase 1 from the microsomal fraction of ram seminal vesicles",9940,NA,NA,NA,NA,"D",159280
18694,"=","IC50",23000,"nM",17047,"B",NA,NA,"In vitro inhibitory activity against prostaglandin G/H synthase 1 from ovine",9940,NA,NA,NA,NA,"D",159282
18694,"=","IC50",10700,"nM",17047,"B",NA,NA,"Inhibitory activity against prostaglandin G/H synthase 1 from ram seminal vesicles",9940,NA,NA,NA,NA,"D",159406
18694,"=","IC50",15135.61,"nM",17047,"B",NA,NA,"Inhibitory activity against prostaglandin G/H synthase 1 (COX-1)",9940,NA,NA,NA,NA,"D",159436
18694,"=","IC50",15330,"nM",17047,"B",NA,NA,"In vitro inhibition against Prostaglandin G/H synthase 1 from ram seminal vesicles",9940,NA,NA,NA,NA,"D",159437
18694,"=","IC50",14000,"nM",96,"B",NA,NA,"Compound was tested for the inhibition of human Prostaglandin G/H synthase 1 (COX-1) in human whole blood",NA,NA,NA,NA,NA,"H",159568
18694,"=","IC50",22900,"nM",96,"B",NA,NA,"Inhibitory concentration against Prostaglandin G/H synthase 1",NA,NA,NA,NA,NA,"H",159572
18694,"=","IC50",900,"nM",11346,"B",NA,NA,"In vitro inhibitory activity against canine prostaglandin G/H synthase 2.",NA,NA,NA,NA,NA,"H",159595
18694,"=","IC50",530,"nM",126,"B",NA,NA,"Biochemical index for Prostaglandin G/H synthase 2 measured as, PGE-2 levels in lipopolysaccharide (LPS)-challenged human whole blood",NA,NA,NA,NA,NA,"H",159599
18694,"=","IC50",1200,"nM",126,"B",NA,NA,"Compound was evaluated for inhibition concentration of prostaglandin G/H synthase 2 in human blood",NA,NA,NA,NA,NA,"H",159601
18694,"=","IC50",40,"nM",126,"B",NA,NA,"In vitro inhibitory activity against human Prostaglandin G/H synthase 2",NA,NA,NA,NA,NA,"H",159604
18694,"=","IC50",54,"nM",126,"B",NA,NA,"Compound was tested for the inhibition of recombinant human Prostaglandin G/H synthase 2 (COX-2)",NA,NA,NA,NA,NA,"H",159733
18694,"=","IC50",40,"nM",126,"B",NA,NA,"In Vitro activity of compound against human recombinant Prostaglandin G/H synthase 2",NA,NA,NA,NA,NA,"H",159743
18694,"=","IC50",40,"nM",126,"B",NA,NA,"In Vitro activity of compound against human recombinant Prostaglandin G/H synthase 2",NA,NA,NA,NA,NA,"H",159743
18694,"=","IC50",70,"nM",126,"B",NA,NA,"In vitro inhibition against human Prostaglandin G/H synthase 2",NA,NA,NA,NA,NA,"H",159745
18694,"=","IC50",79,"nM",126,"B",NA,NA,"In vitro inhibitory activity against human Prostaglandin G/H synthase 2 (COX-2) in 143982 cells",NA,NA,NA,NA,NA,"H",159750
18694,"=","IC50",36,"nM",126,"B","In vitro",NA,"In vitro inhibitory activity against human recombinant prostaglandin G/H synthase 2 expressed in sf-9 cells infected with baculovirus",NA,NA,NA,NA,NA,"H",159754
18694,"=","IC50",1000,"nM",126,"B",NA,NA,"In vitro inhibitory activity against human whole blood Prostaglandin G/H synthase 2",9606,NA,NA,NA,NA,"D",159755
18694,"=","IC50",36,"nM",126,"B",NA,NA,"In vitro inhibitory activity against recombinant human Prostaglandin G/H synthase 2",NA,NA,NA,NA,NA,"H",159759
18694,"=","IC50",56.7,"nM",126,"B",NA,NA,"In vitro inhibitory concentration of compound required to inhibit Prostaglandin G/H synthase 2 enzyme was determined",NA,NA,NA,NA,NA,"H",159764
18694,"=","IC50",40,"nM",126,"B",NA,NA,"In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2)",NA,NA,NA,NA,NA,"H",159768
87221,"=","IC50",2000,"nM",9,"B",NA,NA,"Inhibition of polyGAT phosphorylation",9606,NA,NA,NA,NA,"D",159832
18694,"=","IC50",600,"nM",126,"B",NA,NA,"In vitro percent inhibition of Prostaglandin G/H synthase 2 (COX-2) in human whole blood was determined",NA,NA,NA,NA,NA,"H",159893
18694,"=","IC50",80,"nM",126,"B",NA,NA,"Inhibition of Prostaglandin G/H synthase 2 in 143.98.2 from human osteosarcoma cells",NA,NA,NA,NA,NA,"H",159899
18694,"=","IC50",1100,"nM",126,"B",NA,NA,"Inhibitory activity against prostaglandin G/H synthase 2",NA,NA,NA,NA,NA,"H",159907
18694,"=","IC50",1000,"nM",126,"B",NA,NA,"Inhibition of Prostaglandin G/H synthase 2 in human whole blood",9606,NA,NA,NA,NA,"D",159909
18694,"=","IC50",230,"nM",126,"B",NA,NA,"Inhibition of human Prostaglandin G/H synthase 2",9606,NA,NA,NA,NA,"D",159914
18694,"=","IC50",36,"nM",126,"B","In vitro",NA,"Inhibitory activity against human Prostaglandin G/H synthase 2 expressed in sf-9 cells infected with baculovirus",NA,NA,NA,NA,NA,"H",159915
18694,"=","IC50",56.7,"nM",126,"B",NA,NA,"Inhibitory concentration against Prostaglandin G/H synthase 2",NA,NA,NA,NA,NA,"H",159919
18694,"=","IC50",40,"nM",126,"B",NA,NA,"Inhibitory concentration against human prostaglandin G/H synthase 2 at 25 degrees.",NA,NA,NA,NA,NA,"H",159922
17224,"=","Kd",1.64,"nM",191,"B",NA,NA,"Equilibrium constant for the interaction between inhibitor and HIV-1 Protease",11676,NA,NA,NA,NA,"D",159969
32530,"=","IC50",8.8,"nM",12454,"B",NA,NA,"Inhibition of Protein kinase C alpha",10116,NA,NA,NA,NA,"D",160140
32530,"=","IC50",30.5,"nM",12133,"B",NA,NA,"Inhibition of Protein kinase C beta",10116,NA,NA,NA,NA,"D",160451
32530,"=","IC50",28,"nM",12133,"B",NA,NA,"Inhibition of Protein kinase C beta 1",10116,NA,NA,NA,NA,"D",160470
32530,"=","IC50",105,"nM",10879,"B",NA,NA,"Inhibition of Protein kinase C epsilon",10116,NA,NA,NA,NA,"D",160964
32530,"=","IC50",36.5,"nM",12635,"B",NA,NA,"Inhibition of Protein kinase C gamma (PKC)",10116,NA,NA,NA,NA,"D",161278
87221,"=","IC50",13489.63,"nM",188,"B",NA,NA,"Inhibitory activity tested against protein kinase HER-2",NA,NA,NA,NA,NA,"H",161600
32530,"=","IC50",223375,"nM",104720,"B",NA,NA,"Inhibition of cyclic AMP dependent protein kinase A (PKA)",NA,NA,NA,NA,NA,"H",161910
32530,"=","IC50",21,"nM",104731,"B",NA,NA,"Inhibition of protein kinase C from rat brain (PKC)",10116,NA,NA,NA,NA,"D",162368
32530,"=","IC50",17.2,"nM",104683,"B",NA,NA,"Inhibition of protein kinase C (PKC)",NA,NA,NA,NA,NA,"H",162404
23466,"=","Ki",26,"nM",22226,"B",NA,NA,"The compound was tested for its binding affinity towards stromelysin.",NA,NA,NA,NA,NA,"U",205492
112889,">","Ki",1000,"nM",22226,"B",NA,NA,"The compound was tested for its binding affinity towards stromelysin.",NA,NA,NA,NA,NA,"U",205492
113416,">","Ki",1000,"nM",22226,"B",NA,NA,"The compound was tested for its binding affinity towards stromelysin.",NA,NA,NA,NA,NA,"U",205492
23466,"=","IC50",28,"nM",11109,"B",NA,NA,"Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 100 uM",9606,NA,NA,NA,NA,"D",205495
17224,"=","Ki",0.14,"nM",191,"B",NA,NA,"Dissociation constant obtained by inhibition of Wild-type protease",NA,NA,NA,NA,NA,"H",216596
23466,"=","IC50",13.4,"nM",11154,"B",NA,NA,"Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1)",NA,NA,NA,NA,NA,"H",217867
17224,"=","Ki",16,"nM",191,"B",NA,NA,"Dissociation constant obtained by inhibition of mutant HIV-protease (A-44)",NA,NA,NA,NA,NA,"H",222916
17224,"=","Ki",33,"nM",191,"B",NA,NA,"Dissociation constant obtained by inhibition of mutant HIV-protease (K-60)",NA,NA,NA,NA,NA,"H",222917
17224,"=","Ki",27,"nM",191,"B",NA,NA,"Dissociation constant obtained by inhibition of mutant HIV-protease (V-18)",NA,NA,NA,NA,NA,"H",222918
18694,"=","IC50",1000,"nM",126,"B",NA,NA,"Inhibitory concentration was measured against Cyclooxygenase-2 in human whole blood",NA,NA,"Blood",NA,NA,"H",223551
17224,"=","Kd",1.64,"nM",191,"B",NA,NA,"Binding affinity for human immunodeficiency virus type 1 protease",11676,NA,NA,NA,NA,"D",302137
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibitory activity against human carbonic anhydrase I (hCAI)",9606,NA,NA,NA,NA,"D",302630
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibitory activity against human carbonic anhydrase II (hCAII)",9606,NA,NA,NA,NA,"D",302668
18694,"=","Ki",880,"nM",12896,"B",NA,NA,"Inhibitory activity against human carbonic anhydrase IV (hCAIV)",9606,NA,NA,NA,NA,"D",302669
18694,"=","Ki",290,"nM",11035,"B",NA,NA,"Inhibitory activity against bovine carbonic anhydrase IV (bCAIV)",9913,NA,NA,NA,NA,"D",302691
17224,"=","Ki",0.54,"nM",191,"B",NA,NA,"Inhibition constant for human immunodeficiency virus type 1 protease",11676,NA,NA,NA,NA,"D",302776
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibitory activity against human carbonic anhydrase I at 0.09 uM",9606,NA,NA,NA,NA,"D",303051
18694,"=","Ki",21000,"nM",15,"B",NA,NA,"Inhibitory activity against human carbonic anhydrase II at 0.01 uM",9606,NA,NA,NA,NA,"D",303080
18694,"=","Ki",16000,"nM",12952,"B",NA,NA,"Inhibitory activity against human carbonic anhydrase IX at 0.09 uM",9606,NA,NA,NA,NA,"D",303081
18694,"=","Ki",1010,"nM",20099,"B",NA,NA,"Inhibitory activity against alpha carbonic anhydrase (Co-Cam) from Methanosarcina thermophila",2210,NA,NA,NA,NA,"D",303239
18694,"=","Ki",140,"nM",20099,"B",NA,NA,"Inhibitory activity against alpha carbonic anhydrase (Zn-Cam) from Methanosarcina thermophila",2210,NA,NA,NA,NA,"D",303240
18694,"=","Ki",38500,"nM",20009,"B",NA,NA,"Inhibitory activity against beta carbonic anhydrase (Cab) from Methanobacterium thermoautotrophicum",187420,NA,NA,NA,NA,"D",303344
18694,"=","IC50",33100,"nM",17047,"B",NA,NA,"Inhibition of ovine Prostaglandin G/H synthase 1",9940,NA,NA,NA,NA,"D",305177
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"Inhibition of ovine Prostaglandin G/H synthase 2",9940,NA,NA,NA,NA,"D",305178
18694,"=","IC50",33100,"nM",17047,"B",NA,NA,"In vitro inhibitory concentration against ovine Cyclooxygenase-1",9940,NA,NA,NA,NA,"D",305220
18694,"=","IC50",33100,"nM",17047,"B",NA,NA,"In vitro inhibitory concentration against ovine Cyclooxygenase-1",9940,NA,NA,NA,NA,"D",305220
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"In vitro inhibitory concentration against ovine Cyclooxygenase-2",9940,NA,NA,NA,NA,"D",305221
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"In vitro inhibitory concentration against ovine Cyclooxygenase-2",9940,NA,NA,NA,NA,"D",305221
18694,"=","IC50",1689,"nM",96,"B","In vitro",NA,"Inhibition of human cyclooxygenase-1 expressed in COS cells",9606,NA,NA,NA,NA,"D",305401
18694,"=","IC50",68,"nM",126,"B","In vitro",NA,"Inhibition of human cyclooxygenase-2 expressed in COS cells",9606,NA,NA,NA,NA,"D",305402
18694,"=","IC50",33100,"nM",17047,"B",NA,NA,"In vitro inhibition of ovine prostaglandin G/H synthase 1",9940,NA,NA,NA,NA,"D",305476
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"In vitro inhibition of ovine prostaglandin G/H synthase 2",9940,NA,NA,NA,NA,"D",305477
18694,"=","IC50",33100,"nM",17047,"B",NA,NA,"In vitro inhibitory concentration against ovine Prostaglandin G/H synthase 1",9940,NA,NA,NA,NA,"D",305582
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"In vitro inhibitory concentration against ovine Prostaglandin G/H synthase 2",9940,NA,NA,NA,NA,"D",305583
18694,"=","IC50",14000,"nM",96,"B",NA,NA,"In vitro inhibition of Prostaglandin G/H synthase 1 in human whole blood",9606,NA,NA,NA,NA,"D",305702
18694,"=","IC50",1200,"nM",126,"B",NA,NA,"In vitro inhibition of Prostaglandin G/H synthase 2 in human whole blood",9606,NA,NA,NA,NA,"D",305703
23466,"=","IC50",1,"nM",11989,"B",NA,NA,"In vitro inhibition of A disintegrin and metalloprotease domain 9 (ADAM9)",NA,NA,NA,NA,NA,"H",305750
23466,"=","IC50",8.1,"nM",100155,"B",NA,NA,"In vitro inhibition of A disintegrin and metalloprotease domain 10 (ADAM10)",NA,NA,NA,NA,NA,"H",305773
23466,"=","IC50",7.5,"nM",11473,"B",NA,NA,"In vitro inhibition of A disintegrin and metalloprotease domain 17 (ADAM17, TACE)",NA,NA,NA,NA,NA,"H",305977
18694,"=","IC50",810,"nM",10188,"B",NA,NA,"Inhibitory concentration against p38 alpha MAP kinase calculated by CoMFA model; FlexX score=-12.4 kcal/mol",9606,NA,NA,NA,NA,"D",306018
23466,"=","IC50",5.93,"nM",100154,"B",NA,NA,"Inhibition of A disintegrin and metalloprotease domain 12 (ADAM12) binding in cell based assay",NA,NA,NA,NA,NA,"H",306185
18694,"=","IC50",14000,"nM",96,"B",NA,NA,"In vitro inhibitory concentration against Prostaglandin G/H synthase 1 (COX-1) in human whole blood",9606,NA,NA,NA,NA,"D",306226
18694,"=","IC50",1200,"nM",126,"B",NA,NA,"In vitro inhibitory concentration against Prostaglandin G/H synthase 2 (COX-2) in human whole blood",9606,NA,NA,NA,NA,"D",306227
18694,"=","IC50",2050,"nM",17100,"B",NA,NA,"Inhibitory concentration against Prostaglandin G/H synthase 2 from sheep placenta at 100 uM",9940,NA,NA,NA,NA,"D",306318
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of cloned human carbonic anhydrase II",9606,NA,NA,NA,NA,"D",320722
18694,"=","Ki",16,"nM",12952,"B",NA,NA,"Inhibition of catalytic domain of human recombinant carbonic anhydrase IX",9606,NA,NA,NA,NA,"D",320723
18694,">","IC50",10000,"nM",10193,"B",NA,NA,"Inhibitory concentration against carbonic anhydrase I",9606,NA,NA,NA,NA,"D",321163
18694,"=","IC50",21,"nM",15,"B",NA,NA,"Inhibitory concentration against carbonic anhydrase II",9606,NA,NA,NA,NA,"D",321175
18694,"=","IC50",16,"nM",12952,"B",NA,NA,"Inhibitory concentration against carbonic anhydrase IX",9606,NA,NA,NA,NA,"D",321176
18694,"=","IC50",6.8,"nM",126,"B",NA,NA,"Inhibitory concentration against COX-2; (valus obtained by Kato et al.)",9606,NA,NA,NA,NA,"D",321274
18694,"=","IC50",6,"nM",126,"B",NA,NA,"Inhibitory concentration against COX-2 upon incubation for 15 minutes at 37 degree C",9606,NA,NA,NA,NA,"D",321358
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibitory activity against cloned human CA1",9606,NA,NA,NA,NA,"D",329207
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibitory activity against cloned human CA2",9606,NA,NA,NA,NA,"D",329208
18694,"=","Ki",290,"nM",11035,"B",NA,NA,"Inhibitory activity against CA4 isolated from bovine lung microsomes",9913,NA,NA,NA,NA,"D",329209
18694,"=","Ki",16,"nM",12952,"B",NA,NA,"Inhibitory activity against cloned human CA9",9606,NA,NA,NA,NA,"D",329210
18694,"=","Ki",18,"nM",12209,"B",NA,NA,"Inhibitory activity against cloned human CA12",9606,NA,NA,NA,NA,"D",329211
23466,"=","IC50",6,"nM",13000,"B",NA,NA,"Inhibitory activity against MMP1",9606,NA,NA,NA,NA,"D",330166
23466,"=","IC50",7,"nM",13001,"B",NA,NA,"Inhibitory activity against MMP2",9606,NA,NA,NA,NA,"D",330167
23466,"=","IC50",15,"nM",12592,"B",NA,NA,"Inhibitory activity against MMP9",9606,NA,NA,NA,NA,"D",330169
23466,"=","IC50",13,"nM",11871,"B",NA,NA,"Inhibitory activity against MMP12",9606,NA,NA,NA,NA,"D",330170
23466,"=","IC50",23,"nM",11154,"B",NA,NA,"Inhibitory activity against MMP14",9606,NA,NA,NA,NA,"D",330171
23466,"=","IC50",6,"nM",11043,"B",NA,NA,"Inhibitory activity against MMP15",9606,NA,NA,NA,NA,"D",330172
23466,"=","IC50",8,"nM",11044,"B",NA,NA,"Inhibitory activity against MMP16",9606,NA,NA,NA,NA,"D",330173
23466,"=","IC50",17,"nM",10226,"B",NA,NA,"Inhibitory activity against MMP26",9606,NA,NA,NA,NA,"D",330174
18694,"=","IC50",33100,"nM",17047,"B",NA,NA,"Inhibitory activity against ovine COX1",9940,NA,NA,NA,NA,"D",336945
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"Inhibitory activity against ovine COX2",9940,NA,NA,NA,NA,"D",336946
442943,"=","IC50",35000,"nM",100250,"B",NA,NA,"Ability to displace ethidium bromide from DNA",NA,NA,NA,NA,NA,"M",378543
18694,"=","IC50",3.7,"nM",17047,"B",NA,NA,"Inhibition of COX1",9606,NA,NA,NA,NA,"D",391093
18694,"=","IC50",2.2,"nM",126,"B",NA,NA,"Inhibition of COX2",9606,NA,NA,NA,NA,"D",391094
18694,"=","IC50",26610,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1",9940,NA,NA,NA,NA,"D",403701
18694,"=","IC50",440,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2",9940,NA,NA,NA,NA,"D",403702
18694,"=","IC50",1300,"nM",126,"B",NA,NA,"Activity of COX2 in human heparinized blood assessed as inhibition of LPS-induced PGE2 production after 24 hrs",9606,NA,NA,NA,NA,"D",428860
18694,"=","IC50",14000,"nM",96,"B",NA,NA,"Inhibition of COX1 in human whole blood assessed as TxB2 production after 1 hr",9606,NA,"Blood",NA,NA,"D",428861
17224,"=","Ki",0.28,"nM",22226,"B",NA,NA,"Inhibition of HIV1 protease",11676,NA,NA,NA,NA,"U",430369
18694,"=","IC50",2600,"nM",96,"B",NA,NA,"Inhibition of COX1 in human whole blood assessed as inhibition of calcium ionophore A-23187-stimulated platelet aggregation by measuring TXB2 production",9606,NA,"Blood",NA,NA,"D",430457
18694,"=","IC50",350,"nM",126,"B",NA,NA,"Inhibition of COX2 in human whole blood assessed as inhibition of LPS-stimulated PGE2 production",9606,NA,"Blood",NA,NA,"D",430458
18694,"=","IC50",19030,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by measuring PGE2",9940,NA,NA,NA,NA,"D",437304
18694,"=","IC50",35,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 by measuring PGE2",9606,NA,NA,NA,NA,"D",437305
18694,">","IC50",25000,"nM",11112,"B",NA,NA,"Inhibition of mouse COX2",10090,NA,NA,NA,NA,"D",441961
18694,"=","IC50",210,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1",9940,NA,NA,NA,NA,"D",441962
23466,"=","IC50",1.5,"nM",13000,"B",NA,NA,"Inhibition of MMP1",NA,NA,NA,NA,NA,"H",447904
23466,"=","IC50",1.1,"nM",13001,"B",NA,NA,"Inhibition of MMP2",NA,NA,NA,NA,NA,"H",447905
23466,"=","IC50",1.9,"nM",11109,"B",NA,NA,"Inhibition of MMP3",NA,NA,NA,NA,NA,"H",447906
23466,"=","IC50",0.5,"nM",12592,"B",NA,NA,"Inhibition of MMP9",NA,NA,NA,NA,NA,"H",447907
23466,"=","IC50",13.4,"nM",11154,"B",NA,NA,"Inhibition of MMP14",NA,NA,NA,NA,NA,"H",447908
18694,"=","IC50",33100,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",449249
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",449250
18694,"=","Ki",154000,"nM",10139,"B",NA,NA,"Inhibition of human recombinant CA 3 assessed as CO2 hydration by stopped flow kinetic assay",9606,NA,NA,NA,NA,"D",449604
18694,"=","IC50",540,"nM",126,"B",NA,NA,"Inhibition of COX2 in LPS-induced monocyte assessed as PGE2 production in human whole blood",9606,NA,"Blood",NA,NA,"D",450443
18694,"=","IC50",12500,"nM",96,"B",NA,NA,"Inhibition of COX1 in human whole blood assessed as TXB2 production",9606,NA,"Blood",NA,NA,"D",450444
18694,"=","IC50",14000,"nM",96,"B",NA,NA,"Inhibition of COX1 in human whole blood assessed as effect on A23187-induced thromboxane B2 production",9606,NA,"Blood",NA,NA,"D",452249
18694,"=","IC50",1200,"nM",126,"B",NA,NA,"Inhibition of COX2 in human whole blood assessed as effect on LPS-induced thromboxane B2 production",9606,NA,"Blood",NA,NA,"D",452250
18694,"=","IC50",24300,"nM",96,"B",NA,NA,"Inhibition of COX1",NA,NA,NA,NA,NA,"H",457475
18694,"=","IC50",60,"nM",126,"B",NA,NA,"Inhibition of COX2",NA,NA,NA,NA,NA,"H",457476
18694,"=","IC50",13000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1",9940,NA,NA,NA,NA,"D",461361
18694,"=","IC50",40,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2",9940,NA,NA,NA,NA,"D",461363
18694,"=","IC50",24300,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by chemiluminescent assay",9940,NA,NA,NA,NA,"D",462287
18694,"=","IC50",60,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by chemiluminescent assay",9940,NA,NA,NA,NA,"D",462288
18694,"=","IC50",23470,"nM",96,"B",NA,NA,"Inhibition of COX1 in human whole blood assessed as effect on A-23187-stimulated TxB2 production",9606,NA,"Blood",NA,NA,"D",464017
18694,"=","IC50",300,"nM",126,"B",NA,NA,"Inhibition of COX2 in human whole blood assessed as effect on LPS-stimulated PGE2 production",9606,NA,"Blood",NA,NA,"D",464018
17224,"=","Ki",0.931,"nM",22226,"B",NA,NA,"Inhibition of HIV1 protease",11676,NA,NA,NA,NA,"U",469686
18694,"=","IC50",33100,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immunoassay",9940,NA,NA,NA,NA,"D",469921
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by enzyme immunoassay",9940,NA,NA,NA,NA,"D",469922
18694,"=","IC50",33100,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",471742
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",471743
430152,">","IC50",1e+05,"nM",22226,"B",NA,NA,"Inhibition of PKA",NA,NA,NA,NA,NA,"U",473566
430152,"=","IC50",700,"nM",10368,"B",NA,NA,"Inhibition of CK1delta",NA,NA,NA,NA,NA,"H",473620
430152,"=","IC50",600,"nM",10967,"B",NA,NA,"Inhibition of CK1epsilon",NA,NA,NA,NA,NA,"H",473621
430152,"=","IC50",11000,"nM",11720,"B",NA,NA,"Inhibition of CK1a1",NA,NA,NA,NA,NA,"H",473622
430152,">","IC50",1e+05,"nM",12071,"B",NA,NA,"Inhibition of p34cdc2",NA,NA,NA,NA,NA,"H",473623
430152,">","IC50",1e+05,"nM",11755,"B",NA,NA,"Inhibition of p55fyn",NA,NA,NA,NA,NA,"H",473624
87221,"=","IC50",100,"nM",9,"B",NA,NA,"Inhibition of EGFR autophosphorylation",NA,NA,NA,NA,NA,"H",473816
18694,">","IC50",1e+05,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",478522
18694,"=","IC50",1710,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",478523
17224,"=","Ki",0.07,"nM",22226,"B",NA,NA,"Inhibition of wild-type HIV1 BH10 protease expressed in Escherichia coli by spectrophotometric assay",11676,"BH10",NA,NA,NA,"U",491043
17224,"=","Ki",18,"nM",22226,"B",NA,NA,"Inhibition of HIV1 recombinant protease D30N/N88D mutant expressed in Escherichia coli by spectrophotometric assay",11676,NA,NA,NA,NA,"U",491044
17224,"=","Ki",3.8,"nM",22226,"B",NA,NA,"Inhibition of HIV1 recombinant protease M46I/A71V/V82T/I84V mutant expressed in Escherichia coli by spectrophotometric assay",11676,NA,NA,NA,NA,"U",491045
17224,"=","Ki",3.2,"nM",22226,"B",NA,NA,"Inhibition of HIV1 recombinant protease A71V/V82T/I84V mutant expressed in Escherichia coli by spectrophotometric assay",11676,NA,NA,NA,NA,"U",491046
17224,"=","Ki",10,"nM",22226,"B",NA,NA,"Inhibition of HIV1 recombinant protease V32I/I47A mutant expressed in Escherichia coli by spectrophotometric assay",11676,NA,NA,NA,NA,"U",491047
17224,"=","Ki",2.1,"nM",22226,"B",NA,NA,"Inhibition of HIV1 recombinant protease L10I/I15V/E35D/N37S/R41K/I62V/L63P/A71V/G73S/L90M mutant expressed in Escherichia coli by spectrophotometric assay",11676,NA,NA,NA,NA,"U",491048
17224,"=","Ki",130,"nM",22226,"B",NA,NA,"Inhibition of HIV1 recombinant protease L10I/L24I/L33F/M46L/154V/L63P/A71V/V82A/I84V mutant expressed in Escherichia coli by spectrophotometric assay",11676,NA,NA,NA,NA,"U",491049
17224,"=","Ki",32,"nM",22226,"B",NA,NA,"Inhibition of HIV1 recombinant protease L10F/L19I/K20R/L33F/E35D/M36I/R41K/F53L/I54V/L63P/H69K/A71V/T74P/I84V/L89M/L90M/I93L mutant expressed in Escherichia coli by spectrophotometric assay",11676,NA,NA,NA,NA,"U",491050
17224,"=","Ki",260,"nM",22226,"B",NA,NA,"Ratio of Ki for HIV1 recombinant protease D30N/N88D mutant to Ki for wild-type HIV1 BH10 protease",11676,NA,NA,NA,NA,"U",491051
17224,"=","Ki",54,"nM",22226,"B",NA,NA,"Ratio of Ki for HIV1 recombinant protease M46I/A71V/V82T/I84V mutant to Ki for wild-type HIV1 BH10 protease",11676,NA,NA,NA,NA,"U",491052
17224,"=","Ki",46,"nM",22226,"B",NA,NA,"Ratio of Ki for HIV1 recombinant protease A71V/V82T/I84V mutant to Ki for wild-type HIV1 BH10 protease",11676,NA,NA,NA,NA,"U",491053
17224,"=","Ki",140,"nM",22226,"B",NA,NA,"Ratio of Ki for HIV1 recombinant protease V32I/I47A mutant to Ki for wild-type HIV1 BH10 protease",11676,NA,NA,NA,NA,"U",491054
17224,"=","Ki",30,"nM",22226,"B",NA,NA,"Ratio of Ki for HIV1 recombinant protease L10I/I15V/E35D/N37S/R41K/I62V/L63P/A71V/G73S/L90M mutant to Ki for wild-type HIV1 BH10 protease",11676,NA,NA,NA,NA,"U",491055
17224,"=","Ki",1800,"nM",22226,"B",NA,NA,"Ratio of Ki for HIV1 recombinant protease L10I/L24I/L33F/M46L/154V/L63P/A71V/V82A/I84V mutant to Ki for wild-type HIV1 BH10 protease expressed in Escherichia coli",11676,NA,NA,NA,NA,"U",491056
17224,"=","Ki",450,"nM",22226,"B",NA,NA,"Ratio of Ki for HIV1 recombinant protease L10F/L19I/K20R/L33F/E35D/M36I/R41K/F53L/I54V/L63P/H69K/A71V/T74P/I84V/L89M/L90M/I93L mutant to Ki for wild-type HIV1 BH10 protease",11676,NA,NA,NA,NA,"U",491057
18694,"=","IC50",7700,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",492902
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",492903
18694,"=","IC50",8000,"nM",17019,"B",NA,NA,"Inhibition of COX1 in bovine platelets assessed as formation of 12-hydroxyheptadecatrienoic acid by HPLC",9913,NA,NA,NA,NA,"D",495250
18694,"=","IC50",800,"nM",126,"B",NA,NA,"Inhibition of COX2 in LPS-stimulated human blood",9606,NA,NA,NA,NA,"D",495251
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",497634
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",497635
18694,"=","Ki",10350,"nM",101488,"B",NA,NA,"Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay",1773,NA,NA,NA,NA,"D",497636
18694,"=","Ki",7760,"nM",22226,"B",NA,NA,"Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 3 expressed in Escherichia coli BL21 by stopped flow CO2 hydration assay",83332,NA,NA,NA,NA,"U",497637
23466,"=","IC50",5.2,"nM",11024,"B",NA,NA,"Inhibition of human recombinant MMP13 catalytic domain",9606,NA,NA,NA,NA,"D",507870
23466,"=","IC50",3.3,"nM",13000,"B",NA,NA,"Inhibition of MMP1",NA,NA,NA,NA,NA,"H",507871
23466,"=","IC50",10,"nM",13001,"B",NA,NA,"Inhibition of MMP2",NA,NA,NA,NA,NA,"H",507872
23466,"=","IC50",7,"nM",11109,"B",NA,NA,"Inhibition of MMP3 catalytic domain",NA,NA,NA,NA,NA,"H",507873
23466,"=","IC50",33,"nM",12738,"B",NA,NA,"Inhibition of MMP7",NA,NA,NA,NA,NA,"H",507874
23466,"=","IC50",9.7,"nM",11110,"B",NA,NA,"Inhibition of MMP8 catalytic domain",NA,NA,NA,NA,NA,"H",507875
23466,"=","IC50",6.7,"nM",12592,"B",NA,NA,"Inhibition of MMP9",NA,NA,NA,NA,NA,"H",507876
23466,"=","IC50",4.7,"nM",11154,"B",NA,NA,"Inhibition of MMP14 catalytic domain",NA,NA,NA,NA,NA,"H",507877
23466,"=","IC50",5.1,"nM",11871,"B",NA,NA,"Inhibition of MMP12 catalytic domain",NA,NA,NA,NA,NA,"H",507878
23466,"=","IC50",3.4,"nM",17147,"B",NA,NA,"Inhibition of MMP17 catalytic domain",NA,NA,NA,NA,NA,"H",507879
18694,"=","IC50",0.52,"nM",126,"B",NA,NA,"Inhibition of COX2",NA,NA,NA,NA,NA,"H",510899
18694,"=","IC50",0.52,"nM",126,"B",NA,NA,"Inhibition of COX2",NA,NA,NA,NA,NA,"H",510899
18694,"=","IC50",16000,"nM",96,"B",NA,NA,"Inhibition of COX1 in human whole blood assessed as inhibition of LPS-stimulated PGE2 production by radioimmunoassay",9606,NA,"Blood",NA,NA,"D",511542
18694,"=","IC50",540,"nM",126,"B",NA,NA,"Inhibition of COX2 in human whole blood assessed as inhibition of TXB2 production by radioimmunoassay",9606,NA,"Blood",NA,NA,"D",511543
18694,"=","IC50",1000,"nM",126,"B",NA,NA,"Inhibition of human COX2",9606,NA,NA,NA,NA,"D",511831
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant CA1 by stopped-flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",515849
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant CA2 by stopped-flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",515850
18694,"=","Ki",108,"nM",101385,"B",NA,NA,"Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay",4932,NA,NA,NA,NA,"D",515851
18694,"=","IC50",7700,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",516254
18694,"=","IC50",120,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 by enzyme immuno assay",9606,NA,NA,NA,NA,"D",516255
18694,"=","IC50",7700,"nM",96,"B",NA,NA,"Inhibition of COX1 by enzyme immunoassay",NA,NA,NA,NA,NA,"H",517117
18694,"=","IC50",70,"nM",126,"B",NA,NA,"Inhibition of COX2 by enzyme immunoassay",NA,NA,NA,NA,NA,"H",517118
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",517300
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",517301
18694,"=","Ki",94,"nM",10186,"B",NA,NA,"Inhibition of human full length recombinant carbonic anhydrase 6 by stopped flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",517302
18694,"=","Ki",16,"nM",12952,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 9 catalytic domain by stopped flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",517303
18694,"=","Ki",45,"nM",101402,"B",NA,NA,"Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay",10090,NA,NA,NA,NA,"D",517304
17224,"=","Ki",0.306,"nM",22226,"B",NA,NA,"Inhibition of HIV1 protease",11676,NA,NA,NA,NA,"U",522620
18694,"=","IC50",0.51,"nM",11112,"B",NA,NA,"Inhibition of LPS-induced COX2 activity in C57BL/6J mouse peritoneal macrophages by RIA",10090,"C57BL/6J",NA,NA,NA,"D",527254
18694,"<","IC50",300,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2",9606,NA,NA,NA,NA,"D",530842
18694,">","IC50",1e+05,"nM",96,"B",NA,NA,"Inhibition of human platelet COX1",9606,NA,NA,NA,NA,"D",530843
568326,"=","IC50",2570,"nM",10368,"B",NA,NA,"Inhibition of CK1delta",NA,NA,NA,NA,NA,"H",535967
568326,">","IC50",40000,"nM",10262,"B",NA,NA,"Inhibition of CK1gamma1",NA,NA,NA,NA,NA,"H",535968
568326,"=","IC50",1240,"nM",11720,"B",NA,NA,"Inhibition of CK1alpha",NA,NA,NA,NA,NA,"H",535969
568326,"=","IC50",1000,"nM",22226,"B",NA,NA,"Inhibition of CK1",NA,NA,NA,NA,NA,"U",536051
18694,"=","IC50",1200,"nM",126,"B",NA,NA,"Inhibition of COX2",NA,NA,NA,NA,NA,"H",540069
18694,"=","IC50",14000,"nM",96,"B",NA,NA,"Inhibition of COX1",NA,NA,NA,NA,NA,"H",540070
18694,"=","IC50",7700,"nM",17019,"B",NA,NA,"Inhibition of bovine COX1 by enzyme immunoassay",9913,NA,NA,NA,NA,"D",541847
18694,"=","IC50",120,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 by enzyme immunoassay",9606,NA,NA,NA,NA,"D",541848
87221,">","IC50",10000,"nM",10938,"B",NA,NA,"Inhibition of JAK2",NA,NA,NA,NA,NA,"H",542084
87221,"=","IC50",3380,"nM",10919,"B",NA,NA,"Inhibition of JAK1",NA,NA,NA,NA,NA,"H",542085
87221,">","IC50",10000,"nM",22226,"B","In vitro",NA,"Inhibition of human recombinant GST-tagged JH1 domain (785 to1125) of JAK3 expressed in insect Sf9 cells by ELISA",9606,NA,NA,NA,NA,"U",542093
18694,">","IC50",1e+05,"nM",96,"B","In vitro",NA,"Inhibition of human COX1 expressed in sf9 cells",9606,NA,NA,NA,NA,"D",551732
18694,"=","IC50",80,"nM",126,"B","In vitro",NA,"Inhibition of human COX2 expressed in sf9 cells",9606,NA,NA,NA,NA,"D",551733
23466,"=","IC50",1,"nM",11871,"B",NA,NA,"Inhibition of MMP12",NA,NA,NA,NA,NA,"H",556874
23466,"=","IC50",0.4,"nM",13000,"B",NA,NA,"Inhibition of human recombinant pro-MMP1 by spectrofluorimeter",9606,NA,NA,NA,NA,"D",557952
23466,"=","IC50",0.4,"nM",13001,"B",NA,NA,"Inhibition of human recombinant pro-MMP2 by spectrofluorimeter",9606,NA,NA,NA,NA,"D",557953
23466,"=","IC50",0.6,"nM",12592,"B",NA,NA,"Inhibition of human recombinant pro-MMP9 by spectrofluorimeter",9606,NA,NA,NA,NA,"D",557954
23466,"=","IC50",5.2,"nM",11154,"B",NA,NA,"Inhibition of human recombinant MMP14 catalytic domain by spectrofluorimeter",9606,NA,NA,NA,NA,"D",557956
23466,"=","IC50",26,"nM",11109,"B",NA,NA,"Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter",9606,NA,NA,NA,NA,"D",557957
18694,"=","IC50",7700,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",558062
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",558063
18694,">","IC50",10000,"nM",22226,"B",NA,NA,"Inhibition of potato LOX5 by enzyme immuno assay",4113,NA,NA,NA,NA,"U",558064
18694,"=","IC50",2900,"nM",126,"B",NA,NA,"Inhibition of PGHS2 in human whole blood assessed as inhibition of TXB2 production by radioimmunoassay",9606,NA,"Blood",NA,NA,"D",560031
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydration method",9606,NA,NA,NA,NA,"D",562984
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration method",9606,NA,NA,NA,NA,"D",562985
18694,"=","Ki",10350,"nM",22226,"B",NA,NA,"Inhibition of Mycobacterium tuberculosis H37Rv recombinant beta-carbonic anhydrase 1 expressed in Escherichia coli BL21 by stopped flow CO2 hydration method",83332,NA,NA,NA,NA,"U",562990
17224,"=","IC50",19900,"nM",11398,"B","In vitro",NA,"Inhibition of human MDR1-dependent accumulation of calcein-AM expressed in MDCK2 cells",9606,NA,NA,NA,NA,"D",564893
18694,"=","Ki",1017,"nM",100954,"B",NA,NA,"Inhibition of Candida albicans recombinant Nce103 by stopped-flow CO2 hydration assay",5476,NA,NA,NA,NA,"D",578466
18694,"=","Ki",3056,"nM",22226,"B",NA,NA,"Inhibition of Cryptococcus neoformans recombinant Can2 by stopped-flow CO2 hydration assay",5207,NA,NA,NA,NA,"U",578467
18694,"=","Ki",21,"nM",100954,"B",NA,NA,"Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay",210,NA,NA,NA,NA,"H",578468
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 by stopped-flow CO2 hydrase method",9606,NA,NA,NA,NA,"D",578469
18694,"=","IC50",24300,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by chemiluminescence assay",9940,NA,NA,NA,NA,"D",578488
18694,"=","IC50",60,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by chemiluminescence assay",9940,NA,NA,NA,NA,"D",578489
18694,"=","IC50",33100,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme-immuno assay",9940,NA,NA,NA,NA,"D",583548
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by enzyme-immuno assay",9940,NA,NA,NA,NA,"D",583549
18694,"=","IC50",68,"nM",126,"B","In vitro",NA,"Inhibition of human COX2 expressed in african green monkey COS cells assessed as inhibition of arachidonic acid-stimulated PGE2 production treated 1 hr before arachidonic acid challenge by enzyme immunoassay",9606,NA,NA,NA,NA,"D",583889
18694,"=","IC50",1689,"nM",96,"B","In vitro",NA,"Inhibition of human COX1 expressed in african green monkey COS cells assessed as inhibition of arachidonic acid-stimulated PGE2 treated 1 hr before arachidonic acid challenge by enzyme immunoassay",9606,NA,NA,NA,NA,"D",583890
18694,"=","IC50",63,"nM",126,"B","In vitro",NA,"Inhibition of human COX2 expressed in baculovirus-infected SF9 cells assessed as inhibition of arachidonic acid-stimulated PGE2 production treated 1 hr before arachidonic acid challenge by enzyme immunoassay",9606,NA,NA,NA,NA,"D",583892
18694,">","IC50",1000,"nM",96,"B","In vitro",NA,"Inhibition of human COX1 expressed in baculovirus-infected SF9 cells assessed as inhibition of arachidonic acid-stimulated PGE2 production treated 1 hr before arachidonic acid challenge by enzyme immunoassay",9606,NA,NA,NA,NA,"D",583893
18694,"=","IC50",336,"nM",126,"B",NA,NA,"Inhibition of COX2 in human whole blood assessed as inhibition of lipopolysaccharide-stimulated PGE2 production after 24 hrs by enzyme immunoassay",9606,NA,"Blood",NA,NA,"D",583895
18694,"=","IC50",10194,"nM",96,"B",NA,NA,"Inhibition of COX1 in human whole blood assessed as inhibition of lipopolysaccharide-induced TxB2 production after 30 min by enzyme immunoassay",9606,NA,"Blood",NA,NA,"D",583896
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant CA1 by stopped-flow CO2 assay",9606,NA,NA,NA,NA,"D",587741
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant CA2 by stopped-flow CO2 assay",9606,NA,NA,NA,NA,"D",587742
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant CA2 by stopped-flow hydration assay",9606,NA,NA,NA,NA,"D",588927
18694,"=","Ki",713,"nM",102876,"B",NA,NA,"Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay",1773,NA,NA,NA,NA,"D",588928
18694,"=","IC50",8320,"nM",17047,"B",NA,NA,"Inhibition of ovine COX-1 assessed as inhibition of transformation of AA to PGH2 by EIA",9940,NA,NA,NA,NA,"D",594667
18694,"=","IC50",113,"nM",17100,"B",NA,NA,"Inhibition of ovine COX-2 assessed as inhibition of transformation of AA to PGH2 by EIA",9940,NA,NA,NA,NA,"D",594668
18694,"=","IC50",73400,"nM",22226,"B",NA,NA,"Inhibition of potato LOX-5 assessed as inhibition of hydroperoxide production after 5 mins by EIA",4113,NA,NA,NA,NA,"U",594669
18694,"=","IC50",7700,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immunoassay",9940,NA,NA,NA,NA,"D",598706
18694,"=","IC50",120,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 by enzyme immunoassay",9606,NA,NA,NA,NA,"D",598707
18694,"=","IC50",24300,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by chemiluminescent enzyme assay",9940,NA,NA,NA,NA,"D",599255
18694,"=","IC50",60,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by chemiluminescent enzyme assay",9940,NA,NA,NA,NA,"D",599256
23466,"=","IC50",56.3,"nM",11989,"B",NA,NA,"Inhibition of ADAM9",NA,NA,NA,NA,NA,"H",599356
23466,"=","IC50",263,"nM",100155,"B",NA,NA,"Inhibition of ADAM10",NA,NA,NA,NA,NA,"H",599357
23466,"=","IC50",13.1,"nM",11473,"B",NA,NA,"Inhibition of TACE",NA,NA,NA,NA,NA,"H",599358
568326,"=","IC50",1000,"nM",10368,"B",NA,NA,"Inhibition of human CK1delta",9606,NA,NA,NA,NA,"D",599895
18694,"=","IC50",12500,"nM",96,"B",NA,NA,"Inhibition of COX1 in human whole blood assessed as thromboxane B2 production by RIA",9606,NA,"Blood",NA,NA,"D",607538
18694,"=","IC50",540,"nM",126,"B",NA,NA,"Inhibition of COX2 in human whole blood assessed as inhibition of LPS-induced PGE2 production by RIA",9606,NA,"Blood",NA,NA,"D",607539
18694,"=","IC50",7700,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immunoassay",9940,NA,NA,NA,NA,"D",608986
18694,"=","IC50",120,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 by enzyme immunoassay",9606,NA,NA,NA,NA,"D",608987
18694,"=","IC50",24300,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme chemiluminescent enzyme assay",9940,NA,NA,NA,NA,"D",609605
18694,"=","IC50",60,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by enzyme chemiluminescent enzyme assay",9940,NA,NA,NA,NA,"D",609606
17224,"=","IC50",1.9,"nM",22226,"B",NA,NA,"Inhibition of recombinant wild type HIV1 protease assessed as hydrolysis of fluorogenic substrate",11676,NA,NA,NA,NA,"U",609663
18694,"=","IC50",10000,"nM",22226,"B",NA,NA,"Inhibition of potato tuber 5LOX by polarographic method",4113,NA,NA,NA,NA,"U",612154
32530,"=","IC50",20,"nM",10197,"B",NA,NA,"Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting",9606,NA,NA,NA,NA,"D",616120
32530,"=","IC50",22,"nM",11635,"B",NA,NA,"Inhibition of PKCalpha",NA,NA,NA,NA,NA,"H",616121
442943,"=","EC50",4300,"nM",22222,"B",NA,NA,"Binding affinity to calf thymus DNA assessed as decrease in ethidium bromide fluorescence by FID assay",9913,NA,NA,NA,NA,"M",616829
18694,"=","IC50",2600,"nM",96,"B",NA,NA,"Inhibition of COX1 in human whole blood assessed as TXB2 production by enzyme immunoassay",9606,NA,"Blood",NA,NA,"D",621979
18694,"=","IC50",350,"nM",126,"B",NA,NA,"Inhibition of COX2 in LPS-stimulated human whole blood assessed as PGE2 production by enzyme immunoassay",9606,NA,"Blood",NA,NA,"D",621980
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 assessed as inhibition of PGF2a formation after 20 mins by Ellman's method",9940,NA,NA,NA,NA,"D",630411
18694,"=","IC50",33100,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 assessed as inhibition of PGF2a formation after 20 mins by Ellman's method",9940,NA,NA,NA,NA,"D",630412
18694,"=","IC50",126000,"nM",10452,"B",NA,NA,"Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100",5693,NA,NA,NA,NA,"D",635149
17224,"=","IC50",144000,"nM",10452,"B",NA,NA,"Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100",5693,NA,NA,NA,NA,"D",635149
17224,">","IC50",3e+05,"nM",10452,"B",NA,NA,"Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in presence of 0.01% Triton X-100",5693,NA,NA,NA,NA,"D",635150
18694,">","IC50",4e+05,"nM",10452,"B",NA,NA,"Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in presence of 0.01% Triton X-100",5693,NA,NA,NA,NA,"D",635150
18694,"=","IC50",13100,"nM",96,"B",NA,NA,"Inhibition of COX1 in human whole blood assessed as inhibition of 12-hydroxyheptadecatrienoic acid production by HPLC method",9606,NA,"Blood",NA,NA,"D",638984
18694,"=","IC50",800,"nM",126,"B",NA,NA,"Inhibition of COX2 in human whole blood assessed as inhibition of 12-hydroxyheptadecatrienoic acid production by HPLC method",9606,NA,"Blood",NA,NA,"D",638986
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643923
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643924
18694,"=","Ki",70000,"nM",10139,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 3 after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643925
18694,"=","Ki",880,"nM",12896,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 4 after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643926
18694,"=","Ki",794,"nM",11042,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 5a after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643927
18694,"=","Ki",93,"nM",11016,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 5b after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643928
18694,"=","Ki",94,"nM",10186,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 6 after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643929
18694,"=","Ki",2170,"nM",11060,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 7 after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643930
18694,"=","Ki",16,"nM",12952,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 9 after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643931
18694,"=","Ki",18,"nM",12209,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 12 after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643932
18694,"=","Ki",98,"nM",12923,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 13 after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643933
18694,"=","Ki",689,"nM",11063,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 14 after 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",643934
18694,"=","Ki",45,"nM",101402,"B",NA,NA,"Inhibition of mouse recombinant carbonic anhydrase 15 after 15 mins by stopped-flow CO2 hydration assay",10090,NA,NA,NA,NA,"D",643935
18694,"=","IC50",115900,"nM",17047,"B",NA,NA,"Inhibition of sheep COX1 by enzyme immunoassay",9940,NA,NA,NA,NA,"D",644674
18694,"=","IC50",65,"nM",126,"B",NA,NA,"Inhibition of human COX2 by enzyme immunoassay",9606,NA,NA,NA,NA,"D",644675
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of wild type human recombinant carbonic anhydrase 1 expressed in Escherichia coli BL21 (DE3) after 15 mins by CO2 hydration method",9606,NA,NA,NA,NA,"D",647167
18694,"=","Ki",52300,"nM",22226,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 Phe91Asn mutant expressed in Escherichia coli BL21 (DE3) after 15 mins by CO2 hydration method",9606,NA,NA,NA,NA,"U",647168
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 after 15 mins by CO2 hydration method",9606,NA,NA,NA,NA,"D",647169
18694,"=","IC50",115900,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by EIA",9940,NA,NA,NA,NA,"D",651418
18694,"=","IC50",65,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 by EIA",9606,NA,NA,NA,NA,"D",651419
18694,"=","IC50",6860,"nM",17047,"B",NA,NA,"Inhibition of sheep COX1 by spectrophotometry",9940,NA,NA,NA,NA,"D",658293
18694,"=","IC50",100,"nM",17100,"B",NA,NA,"Inhibition of sheep COX2 by spectrophotometry",9940,NA,NA,NA,NA,"D",658294
18694,"=","IC50",60,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by chemiluminescence assay",9940,NA,NA,NA,NA,"D",659985
18694,"=","IC50",24300,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by chemiluminescence assay",9940,NA,NA,NA,NA,"D",659986
18694,"=","IC50",24300,"nM",101416,"B",NA,NA,"Inhibition of sheep COX1",9940,NA,NA,NA,NA,"D",662814
18694,"=","IC50",60,"nM",103518,"B",NA,NA,"Inhibition of sheep COX2",9940,NA,NA,NA,NA,"D",662815
442943,"=","Potency",31622.8,"nM",103687,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",9796,NA,NA,NA,NA,"D",688170
641194,"=","Potency",3162.3,"nM",103687,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",9796,NA,NA,NA,NA,"D",688170
87221,"=","IC50",7700,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: A biochemical assay using the ADP-Hunter methodology, purified TAg, and ATP to identify compounds that inhibit the ATPase activity of Tag - Counter Screen. (Class of assay: confirmatory) [Related pubchem assays: 1903, 1909, 2102 ]",NA,NA,NA,NA,NA,"U",688523
87221,"=","Potency",35481.3,"nM",103069,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ",9606,NA,NA,NA,NA,"D",688724
491436,"=","Potency",25118.9,"nM",103069,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ",9606,NA,NA,NA,NA,"D",688724
87221,"=","Potency",8912.5,"nM",103069,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ",9606,NA,NA,NA,NA,"D",688724
87221,"=","Potency",35481.3,"nM",103069,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ",9606,NA,NA,NA,NA,"D",688724
23721,"=","Potency",22387.2,"nM",103657,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",9606,NA,NA,NA,NA,"D",688739
87221,"=","Potency",10000,"nM",103657,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",9606,NA,NA,NA,NA,"D",688739
442943,"=","Potency",25118.9,"nM",103657,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",9606,NA,NA,NA,NA,"D",688739
87221,"=","Potency",15848.9,"nM",103657,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",9606,NA,NA,NA,NA,"D",688739
491436,"=","Potency",14125.4,"nM",103657,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",9606,NA,NA,NA,NA,"D",688739
87221,"=","Potency",15848.9,"nM",103657,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",9606,NA,NA,NA,NA,"D",688739
87221,"=","Potency",14125.4,"nM",103657,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",9606,NA,NA,NA,NA,"D",688739
18694,"<","IC50",300,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 after 45 mins",9606,NA,NA,NA,NA,"D",696154
18694,">","IC50",1e+05,"nM",96,"B",NA,NA,"Inhibition of human platelets COX1 after 2 mins",9606,NA,NA,NA,NA,"D",696155
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant CA1 by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",700655
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant CA2 by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",700656
18694,"=","Ki",34.2,"nM",102979,"B",NA,NA,"Inhibition of Stylophora pistillata carbonic anhydrase by stopped-flow CO2 hydration assay",50429,NA,NA,NA,NA,"D",700658
18694,"=","Ki",690,"nM",103851,"B",NA,NA,"Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay",50429,NA,NA,NA,NA,"D",700659
18694,"=","IC50",40,"nM",126,"B",NA,NA,"Inhibition of human COX2",9606,NA,NA,NA,NA,"D",717095
18694,"=","IC50",15000,"nM",96,"B",NA,NA,"Inhibition of human COX1",9606,NA,NA,NA,NA,"D",717096
18694,">","IC50",4000,"nM",17047,"B",NA,NA,"Inhibition of ovine purified COX1 after 20 mins",9940,NA,NA,NA,NA,"D",718976
18694,"=","IC50",30,"nM",11112,"B",NA,NA,"Inhibition of mouse purified COX2 after 20 mins",10090,NA,NA,NA,NA,"D",718977
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human carbonic anhydrase I by spectrophotometry at pH 7.5",9606,NA,NA,NA,NA,"D",726066
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human carbonic anhydrase II by spectrophotometry at pH 7.5",9606,NA,NA,NA,NA,"D",726067
18694,"=","Ki",128,"nM",22226,"B",NA,NA,"Inhibition of Brucella suis carbonic anhydrase II by spectrophotometry at pH 8.3",29461,NA,NA,NA,NA,"U",726070
18694,"=","Ki",18,"nM",22226,"B",NA,NA,"Inhibition of Brucella suis carbonic anhydrase I by spectrophotometry at pH 8.3",29461,NA,NA,NA,NA,"U",726071
18694,"=","IC50",8100,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 assessed as PGF2alpha level by EIA",9940,NA,NA,NA,NA,"D",727035
18694,"=","IC50",50,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 assessed as PGF2alpha level by EIA",9940,NA,NA,NA,NA,"D",727036
18694,">","IC50",10000,"nM",22226,"B",NA,NA,"Inhibition of potato 5-LOX assessed as hydroperoxides production by EIA",4113,NA,NA,NA,NA,"U",727037
18694,"=","IC50",9400,"nM",17047,"B",NA,NA,"Inhibition of ovine COX-1 by fluorescence assay",9940,NA,NA,NA,NA,"D",728013
18694,"=","IC50",30,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX-2 by fluorescence assay",9606,NA,NA,NA,NA,"D",728014
18694,"=","IC50",150,"nM",126,"B",NA,NA,"Inhibition of COX2",NA,NA,NA,NA,NA,"H",728883
87221,NA,"Potency",11220.2,"nM",104678,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]",9606,NA,NA,NA,NA,"D",737065
87221,NA,"Potency",14125.4,"nM",104678,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]",9606,NA,NA,NA,NA,"D",737065
87221,NA,"Potency",25118.9,"nM",104678,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]",9606,NA,NA,NA,NA,"D",737065
160475,NA,"Potency",25118.9,"nM",104678,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]",9606,NA,NA,NA,NA,"D",737065
18694,"=","IC50",10,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX-2 after 2 mins by fluorescence assay",9606,NA,NA,NA,NA,"D",742953
18694,">","IC50",1000,"nM",11727,"B",NA,NA,"Inhibition of human recombinant soluble epoxide hydrolase after 10 mins by fluorescent-based assay",9606,NA,NA,NA,NA,"D",742954
18694,">","IC50",1e+05,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 after 5 mins by enzyme immunoassay",9940,NA,NA,NA,NA,"D",744565
18694,"=","IC50",300,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 after 5 mins by enzyme immunoassay",9940,NA,NA,NA,NA,"D",744566
18694,">","IC50",50000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 assessed as PGF2alpha production from PGH2 after 5 mins by enzyme immunoassay",9940,NA,NA,NA,NA,"D",748671
18694,"=","IC50",300,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 assessed as PGF2alpha production from PGH2 after 5 mins by enzyme immunoassay",9940,NA,NA,NA,NA,"D",748672
18694,"=","IC50",24300,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by chemiluminescent assay",9940,NA,NA,NA,NA,"D",750656
18694,"=","IC50",60,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by chemiluminescent assay",9940,NA,NA,NA,NA,"D",750657
485738,NA,"Potency",1000,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
87221,NA,"Potency",17782.8,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
491436,NA,"Potency",6510.4,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
491436,NA,"Potency",6510.4,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
485738,NA,"Potency",20587.8,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
485738,NA,"Potency",1000,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
485738,NA,"Potency",20587.8,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
491436,NA,"Potency",891.3,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
485738,NA,"Potency",1000,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
485738,NA,"Potency",20587.8,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
491436,NA,"Potency",6510.4,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
491436,NA,"Potency",6510.4,"nM",22226,"B",NA,"confirmatory","PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",NA,NA,NA,NA,NA,"U",752359
442943,"=","IC50",250720,"nM",102878,"B",NA,NA,"Inhibition of Mycobacterium tuberculosis pantothenate synthetase by high throughput screening method",1773,NA,NA,NA,NA,"D",753217
18694,"=","IC50",7700,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",753438
18694,"=","IC50",70,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 by enzyme immuno assay",9606,NA,NA,NA,NA,"D",753439
18694,"=","IC50",7000,"nM",96,"B",NA,NA,"Inhibition of human whole blood COX-1 assessed as production of TXB2 after 24 hrs by EIA",9606,NA,NA,NA,NA,"D",762068
18694,"=","IC50",190,"nM",126,"B",NA,NA,"Inhibition of human whole blood COX-2 assessed as production of PGE2 after 24 hrs by EIA",9606,NA,NA,NA,NA,"D",762069
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 at pH 7.5 by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",762736
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 at pH 7.5 by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",762737
18694,"=","Ki",5830,"nM",22226,"B",NA,NA,"Inhibition of Salmonella Typhimurium recombinant carbonic anhydrase 1 at pH 8.3 by stopped flow CO2 hydration assay",90371,NA,NA,NA,NA,"U",762742
18694,"=","Ki",6110,"nM",22226,"B",NA,NA,"Inhibition of Salmonella Typhimurium recombinant carbonic anhydrase 2 at pH 8.3 by stopped flow CO2 hydration assay",90371,NA,NA,NA,NA,"U",762743
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human carbonic anhydrase 1-catalyzed CO2 hydration activity by stopped flow assay",9606,NA,NA,NA,NA,"D",770696
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human carbonic anhydrase 2-catalyzed CO2 hydration activity by stopped flow assay",9606,NA,NA,NA,NA,"D",770697
18694,"=","Ki",16,"nM",12952,"B",NA,NA,"Inhibition of human carbonic anhydrase 9-catalyzed CO2 hydration activity by stopped flow assay",9606,NA,NA,NA,NA,"D",770698
18694,"=","Ki",18,"nM",12209,"B",NA,NA,"Inhibition of human carbonic anhydrase 12-catalyzed CO2 hydration activity by stopped flow assay",9606,NA,NA,NA,NA,"D",770699
18694,"=","IC50",7700,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",772485
18694,"=","IC50",70,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",772567
17224,"=","IC50",13797,"nM",20075,"B","In vitro",NA,"DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)",9986,NA,"Reticulocytes",NA,NA,"D",774644
17224,"=","IC50",44500,"nM",104322,"B","In vitro",NA,"DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)",9913,NA,"Uterus",NA,NA,"D",774670
17224,"=","Ki",5804,"nM",104322,"B","In vitro",NA,"DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)",9913,NA,"Uterus",NA,NA,"D",774670
18694,"=","Ki",2362,"nM",104322,"B","In vitro",NA,"DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)",9913,NA,"Uterus",NA,NA,"D",774670
18694,"=","IC50",18109,"nM",104322,"B","In vitro",NA,"DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)",9913,NA,"Uterus",NA,NA,"D",774670
17224,"=","IC50",22503,"nM",11639,"B","In vitro",NA,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",562,NA,NA,NA,NA,"D",774678
17224,"=","IC50",18224,"nM",10188,"B","In vitro",NA,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",562,NA,NA,NA,NA,"D",774680
17224,"=","IC50",14590,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",10116,"Wistar","Brain",NA,"membranes","U",774713
17224,"=","Ki",12969,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",10116,"Wistar","Brain",NA,"membranes","U",774713
17224,"=","Ki",6324,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",10116,"Wistar","Cerebral cortex",NA,"membranes","U",774714
17224,"=","IC50",9840,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",10116,"Wistar","Cerebral cortex",NA,"membranes","U",774714
18694,"=","Ki",15815,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",10116,"Wistar","Cerebral cortex",NA,"membranes","U",774714
18694,"=","IC50",24601,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",10116,"Wistar","Cerebral cortex",NA,"membranes","U",774714
17224,"=","Ki",1686,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",10116,"Wistar","Brain (except cerebellum)",NA,"membranes","U",774723
17224,"=","IC50",1881,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",10116,"Wistar","Brain (except cerebellum)",NA,"membranes","U",774723
18694,"=","IC50",16854,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",10116,"Wistar","Brain (except cerebellum)",NA,"membranes","U",774723
18694,"=","Ki",15111,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",10116,"Wistar","Brain (except cerebellum)",NA,"membranes","U",774723
17224,"=","IC50",36389,"nM",12832,"B","In vitro",NA,"DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)",562,NA,NA,NA,"membranes","D",774726
17224,"=","Ki",24259,"nM",12832,"B","In vitro",NA,"DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)",562,NA,NA,NA,"membranes","D",774726
17224,"=","IC50",21110,"nM",248,"B","In vitro",NA,"DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)",9606,NA,"Platelets",NA,NA,"D",774727
17224,"=","IC50",18380,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",10116,"Wistar","Brain",NA,"membranes","U",774732
17224,"=","Ki",17862,"nM",22226,"B","In vitro",NA,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",10116,"Wistar","Brain",NA,"membranes","U",774732
18694,"=","IC50",181,"nM",15,"B","In vitro",NA,"DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA))",9606,NA,"Erythrocytes",NA,NA,"D",774734
18694,"=","IC50",723,"nM",96,"B","In vitro",NA,"DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid)",9606,NA,"Platelets",NA,NA,"D",774741
23466,"=","IC50",0.41,"nM",11154,"B",NA,NA,"Inhibition of MMP14",NA,NA,NA,NA,NA,"H",785744
23466,"=","IC50",0.05,"nM",12592,"B",NA,NA,"Inhibition of MMP9",NA,NA,NA,NA,NA,"H",785746
23466,"=","IC50",7.62,"nM",11109,"B",NA,NA,"Inhibition of MMP3",NA,NA,NA,NA,NA,"H",785747
23466,"=","IC50",0.2,"nM",13000,"B",NA,NA,"Inhibition of MMP1",NA,NA,NA,NA,NA,"H",785748
18694,"=","IC50",120,"nM",126,"B",NA,NA,"Inhibition of COX2 by chemiluminescent enzyme assay",NA,NA,NA,NA,NA,"H",787160
18694,"=","IC50",27500,"nM",96,"B",NA,NA,"Inhibition of COX1 by chemiluminescent enzyme assay",NA,NA,NA,NA,NA,"H",787161
18694,"=","IC50",100,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX-2 assessed as PGF2alpha production by enzyme immunoassay",9606,NA,NA,NA,NA,"D",791243
18694,"=","IC50",34500,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 assessed as PGF2alpha production by enzyme immunoassay",9940,NA,NA,NA,NA,"D",791244
18694,"=","IC50",200,"nM",126,"B",NA,NA,"Inhibition of COX2 assessed as inhibition of PGE2 production using arachidonic acid as substrate after 10 mins by ELISA",NA,NA,NA,NA,NA,"H",797428
18694,"=","IC50",12470,"nM",96,"B",NA,NA,"Inhibition of platelet COX1-mediated TXB2 production in LPS-induced human whole blood after 60 mins by radioimmunoassay",9606,NA,"Blood",NA,NA,"D",799226
18694,"=","IC50",540,"nM",126,"B",NA,NA,"Inhibition of COX2-mediated PGE2 production in LPS-induced human whole blood after 60 mins by radioimmunoassay",9606,NA,"Blood",NA,NA,"D",799227
18694,"=","Ki",732,"nM",104449,"B",NA,NA,"Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay",85810,NA,NA,NA,NA,"D",801827
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",801828
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",801829
18694,"=","IC50",48000,"nM",10612,"B",NA,NA,"Inhibition of recombinant PDK1 using RPRAATF as substrate by scintillation counting",NA,NA,NA,NA,NA,"H",803090
18694,"=","IC50",21610,"nM",17019,"B",NA,NA,"Inhibition of bovine COX1 assessed as PGE2 formation preincubated for 10 mins by ELISA",9913,NA,NA,NA,NA,"D",804539
18694,"=","IC50",360,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 assessed as PGE2 formation preincubated for 10 mins by ELISA",9940,NA,NA,NA,NA,"D",804540
18694,"=","Ki",421,"nM",22226,"B",NA,NA,"Inhibition of human wild type carbonic anhydrase 2 Asn67Ile mutant expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"U",805627
18694,"=","Ki",76.8,"nM",22226,"B",NA,NA,"Inhibition of human wild type carbonic anhydrase 2 Gln92Val mutant expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"U",805628
18694,"=","Ki",369,"nM",22226,"B",NA,NA,"Inhibition of human wild type carbonic anhydrase 2 Leu204Ser mutant expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"U",805629
18694,"=","IC50",15000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by fluorescence assay",9940,NA,NA,NA,NA,"D",805634
18694,"=","IC50",40,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 by fluorescence assay",9606,NA,NA,NA,NA,"D",805635
18694,"=","IC50",10000,"nM",17047,"B",NA,NA,"Competitive inhibition of ovine COX1 by enzyme immunoassay",9940,NA,NA,NA,NA,"D",806009
18694,"=","IC50",60,"nM",126,"B",NA,NA,"Competitive inhibition of human recombinant COX2 by enzyme immunoassay",9606,NA,NA,NA,NA,"D",806010
18694,"=","IC50",7700,"nM",17047,"B",NA,NA,"Inhibition of ovine COX-1 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",806717
18694,"=","IC50",70,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX-2 by enzyme immuno assay",9606,NA,NA,NA,NA,"D",806718
17224,"=","IC50",9,"nM",22226,"B",NA,NA,"Inhibition of wild type HIV-1 protease assessed as hydrolysis of fluorogenic substrate Abz-Thr-Ile-Nle-Phe(NO2)-Gln-Arg after 10 mins by fluorescence assay",11676,NA,NA,NA,NA,"U",813281
18694,">","IC50",50000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",815719
18694,"=","IC50",280,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by enzyme immuno assay",9940,NA,NA,NA,NA,"D",815720
18694,"=","IC50",30,"nM",126,"B",NA,NA,"Inhibition of COX2 by fluorescence assay",NA,NA,NA,NA,NA,"H",817254
18694,"=","IC50",115000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by enzymatic fluorescence assay",9940,NA,NA,NA,NA,"D",822272
18694,"=","IC50",60,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 by enzymatic fluorescence assay",9606,NA,NA,NA,NA,"D",822273
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human carbonic anhydrase 2 preincubated for 15 mins measured for 10 to 100 sec by stopped-flow method",9606,NA,NA,NA,NA,"D",826238
18694,"=","Ki",3056,"nM",22226,"B",NA,NA,"Inhibition of Cryptococcus neoformans Can2 preincubated for 15 mins measured for 10 to 100 sec by stopped-flow method",5207,NA,NA,NA,NA,"U",826239
18694,"=","Ki",1017,"nM",22226,"B",NA,NA,"Inhibition of Candida albicans CaNce103 preincubated for 15 mins measured for 10 to 100 sec by stopped-flow method",5476,NA,NA,NA,NA,"U",826240
18694,"=","Ki",34800,"nM",22226,"B","In vitro",NA,"Inhibition of GST-tagged Malassezia globosa ATCC 96807/CBS 7966 MG-CA expressed in Escherichia coli BL21(DE3) cells preincubated for 15 mins measured for 10 to 100 sec by stopped-flow method",425265,NA,NA,NA,NA,"U",826242
18694,">","IC50",40000,"nM",101071,"B",NA,NA,"Inhibition of norA-mediated EtBr efflux in Staphylococcus aureus SA1199B overexpressing norA and expressing A116E GrlA mutation by fluorometry",1280,"SA1199B",NA,NA,NA,"D",826866
17224,"=","Kd",3.4,"nM",22226,"B",NA,NA,"Binding affinity to Human immunodeficiency virus 1 protease by SPR biosensor interaction analysis at pH 7.4",11676,NA,NA,NA,NA,"U",830319
17224,"=","Kd",2.99,"nM",22226,"B",NA,NA,"Binding affinity to Human immunodeficiency virus 1 protease by SPR biosensor interaction analysis at pH 5.1",11676,NA,NA,NA,NA,"U",830320
17224,"=","Kd",37.6,"nM",22226,"B",NA,NA,"Binding affinity to Human immunodeficiency virus 1 protease by SPR biosensor interaction analysis at pH 4.1",11676,NA,NA,NA,NA,"U",830321
18694,"=","IC50",140,"nM",126,"B",NA,NA,"Inhibition of COX2 in human whole blood assessed as inhibition of LPS-induced PGE2 synthesis up to 24 hrs by radioimmunoassay",9606,NA,"Blood",NA,NA,"D",830633
18694,"=","IC50",15000,"nM",96,"B",NA,NA,"Inhibition of COX1",9606,NA,NA,NA,NA,"D",832832
18694,"=","IC50",40,"nM",126,"B",NA,NA,"Inhibition of COX2",9606,NA,NA,NA,NA,"D",832833
18694,"=","IC50",54,"nM",126,"B",NA,NA,"Inhibition of COX-2 in human HNSCC 1483 cells using [14C] arachidonic acid as substrate preincubated for 30 mins before substrate addition measured after 30 mins",9606,NA,NA,NA,NA,"D",832841
568326,"=","IC50",1000,"nM",11720,"B",NA,NA,"Inhibition of CK1 using KRRRALS(p)VASLPGL as substrate after 40 mins by scintillation counter",NA,NA,NA,NA,NA,"H",842102
18694,"=","IC50",100,"nM",126,"B",NA,NA,"Inhibition of COX-2 by chemiluminescent assay",NA,NA,NA,NA,NA,"H",854964
18694,"=","IC50",10000,"nM",96,"B",NA,NA,"Inhibition of COX-1 by chemiluminescent assay",NA,NA,NA,NA,NA,"H",854967
18694,"=","IC50",15000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 using arachidonic acid as substrate incubated for 1 min prior to substrate addition measured for 25 secs by TMPD-based chromogenic assay",9940,NA,NA,NA,NA,"D",855887
18694,"=","IC50",42,"nM",126,"B","In vitro",NA,"Inhibition of human recombinant COX2 expressed in insect cells using arachidonic acid as substrate incubated for 1 min prior to substrate addition measured for 25 secs by TMPD-based chromogenic assay",9606,NA,NA,NA,NA,"D",855888
442943,"=","IC50",270000,"nM",22226,"B",NA,NA,"Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay",11676,NA,NA,NA,NA,"U",856669
87221,">","IC50",333000,"nM",103069,"B",NA,NA,"Inhibition of human recombinant Tdp1 assessed as conversion of 14-mer 5'-32P-labeled 3'-phosphotyrosyl DNA substrate N14Y to 14-mer 5'-32P-labeled 3'-phosphate DNA product N14P after 15 mins by PAGE analysis",9606,NA,NA,NA,NA,"D",864727
18694,"=","Ki",7760,"nM",101546,"B",NA,NA,"Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase Rv3273 pre-incubated for 15 mins by stopped-flow CO2 hydration method",1773,NA,NA,NA,NA,"D",878775
18694,"=","Ki",713,"nM",102876,"B",NA,NA,"Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase Rv3588c pre-incubated for 15 mins by stopped-flow CO2 hydration method",1773,NA,NA,NA,NA,"D",878776
18694,"=","Ki",10350,"nM",101488,"B",NA,NA,"Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase Rv1284 pre-incubated for 15 mins by stopped-flow CO2 hydration method",1773,NA,NA,NA,NA,"D",878777
18694,"=","Ki",689,"nM",11063,"B",NA,NA,"Inhibition of human recombinant CA14 catalytic domain pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878778
18694,"=","Ki",98,"nM",12923,"B",NA,NA,"Inhibition of human recombinant CA13 catalytic domain pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878779
18694,"=","Ki",16,"nM",12952,"B",NA,NA,"Inhibition of human recombinant CA9 catalytic domain pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878780
18694,"=","Ki",18,"nM",12209,"B",NA,NA,"Inhibition of human recombinant CA12 catalytic domain pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878781
18694,"=","Ki",2170,"nM",11060,"B",NA,NA,"Inhibition of human recombinant full length CA7 pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878782
18694,"=","Ki",94,"nM",10186,"B",NA,NA,"Inhibition of human recombinant full length CA6 pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878783
18694,"=","Ki",93,"nM",11016,"B",NA,NA,"Inhibition of human recombinant full length CA5B pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878784
18694,"=","Ki",794,"nM",11042,"B",NA,NA,"Inhibition of human recombinant full length CA5A pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878785
18694,"=","Ki",880,"nM",12896,"B",NA,NA,"Inhibition of human recombinant full length CA4 pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878786
18694,"=","Ki",7400,"nM",10139,"B",NA,NA,"Inhibition of human recombinant full length CA3 pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878787
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant full length CA2 pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878788
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant full length CA1 pre-incubated for 15 mins by stopped-flow CO2 hydration method",9606,NA,NA,NA,NA,"D",878789
18694,">","Ki",1000,"nM",22226,"B",NA,NA,"Inhibition of recombinant Vibrio cholerae carbonic anhydrase expressed in Escherichia coli (DE3) preincubated for 15 mins by stopped-flow CO2 hydrase assay",666,NA,NA,NA,NA,"U",878955
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by stopped-flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",878956
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 preincubated for 15 mins by stopped-flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",878957
18694,"=","IC50",24300,"nM",17047,"B",NA,NA,"Inhibition of Ovis aries (sheep) COX1 using arachidonic acid as substrate using cyclic naphthalene hydrazide by chemiluminescence assay",9940,NA,NA,NA,NA,"D",900682
18694,"=","IC50",60,"nM",17100,"B",NA,NA,"Inhibition of Ovis aries (sheep) COX2 using arachidonic acid as substrate using cyclic naphthalene hydrazide by chemiluminescence assay",9940,NA,NA,NA,NA,"D",900683
18694,"=","IC50",60,"nM",17100,"B",NA,NA,"Inhibition of Ovis aries (sheep) COX2 using arachidonic acid as substrate using cyclic naphthalene hydrazide by chemiluminescence assay",9940,NA,NA,NA,NA,"D",900685
18694,"=","IC50",24300,"nM",17047,"B",NA,NA,"Inhibition of Ovis aries (sheep) COX1 using arachidonic acid as substrate using cyclic naphthalene hydrazide by chemiluminescence assay",9940,NA,NA,NA,NA,"D",900686
18694,"=","IC50",60,"nM",11111,"B",NA,NA,"Inhibition of Bos taurus (bovine) COX-2 by Chemoiluminescence assay",9913,NA,NA,NA,NA,"D",909236
18694,"=","IC50",24300,"nM",17019,"B",NA,NA,"Inhibition of Bos taurus (bovine) COX-1 by Chemoiluminescence assay",9913,NA,NA,NA,NA,"D",909237
18694,"=","IC50",57,"nM",126,"B",NA,NA,"Inhibition of COX2 (unknown origin)",9606,NA,NA,NA,NA,"D",923079
18694,"=","IC50",57,"nM",17100,"B",NA,NA,"Inhibition of Ovis aries (sheep) COX-2 assessed as decrease in PGF2a production from PGH2 upon reduction with stannous chloride using arachidonic acid as substrate pre-incubated with enzyme for 5 min prior to substrate addition by enzyme immunoassay",9940,NA,NA,NA,NA,"D",923213
18694,"=","IC50",23000,"nM",17047,"B",NA,NA,"Inhibition of Ovis aries (sheep) COX-1 assessed as decrease in PGF2a production from PGH2 upon reduction with stannous chloride using arachidonic acid as substrate pre-incubated with enzyme for 5 min prior to substrate addition by enzyme immunoassay",9940,NA,NA,NA,NA,"D",923216
18694,"=","IC50",60,"nM",17100,"B",NA,NA,"Inhibition of Ovis aries (sheep) cyclooxygenase-2 using arachidonic acid as substrate by chemiluminescent assay",9940,NA,NA,NA,NA,"D",931185
18694,"=","IC50",24300,"nM",17047,"B",NA,NA,"Inhibition of Ovis aries (sheep) cyclooxygenase-1 using arachidonic acid as substrate by chemiluminescent assay",9940,NA,NA,NA,NA,"D",931186
18694,"=","IC50",7700,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1",9940,NA,NA,NA,NA,"D",937009
18694,"=","IC50",70,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2",9606,NA,NA,NA,NA,"D",937010
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",938521
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",938522
18694,"=","Ki",91.1,"nM",22226,"B",NA,NA,"Inhibition of Trypanosoma cruzi CL Brener recombinant alpha-carbonic anhydrase expressed in insect Sf9 cell Baculovirus system by stopped flow CO2 hydration assay",5693,"CL Brener",NA,NA,NA,"U",938798
18694,"=","IC50",120,"nM",11112,"B",NA,NA,"Inhibition of COX-2 in mouse RAW264.7 cells assessed as decrease in LPS-induced PGE2 production",10090,NA,NA,NA,NA,"D",947089
18694,"=","IC50",100,"nM",126,"B",NA,NA,"Inhibition of COX-2 (unknown origin) by chemiluminescence assay",9606,NA,NA,NA,NA,"D",947090
18694,"=","IC50",27500,"nM",96,"B",NA,NA,"Inhibition of COX-1 (unknown origin) by chemiluminescence assay",9606,NA,NA,NA,NA,"D",947093
23466,"=","IC50",4.7,"nM",11154,"B",NA,NA,"Inhibition of human recombinant MMP14 catalytic domain using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis",9606,NA,NA,NA,NA,"D",948651
23466,"=","IC50",5.2,"nM",11024,"B",NA,NA,"Inhibition of human recombinant MMP13 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis",9606,NA,NA,NA,NA,"D",948652
23466,"=","IC50",10,"nM",13001,"B",NA,NA,"Inhibition of human recombinant MMP2 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis",9606,NA,NA,NA,NA,"D",948653
23466,"=","IC50",3.3,"nM",13000,"B",NA,NA,"Inhibition of human recombinant MMP1 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis",9606,NA,NA,NA,NA,"D",948654
18694,"=","IC50",870,"nM",126,"B",NA,NA,"Inhibition of COX2 in human blood assessed as TxB2 level after 1 hr by enzyme immunoassay",9606,NA,NA,NA,NA,"D",951243
18694,"=","IC50",6650,"nM",96,"B",NA,NA,"Inhibition of COX1 in human blood assessed as PGE2 level incubated for 15 mins prior to LPS-challenge measured after 24 hrs by enzyme immunoassay",9606,NA,NA,NA,NA,"D",951244
18694,"=","Ki",116,"nM",22226,"B",NA,NA,"Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay",5478,NA,NA,NA,NA,"U",955917
18694,"=","Ki",6.9,"nM",22226,"B",NA,NA,"Inhibition of Sulfurihydrogenibium yellowstonense YO3AOP1 recombinant carbonic anhydrase preincubated for 15 mins by CO2 hydration stopped-flow assay",304736,"YO3AOP1",NA,NA,NA,"U",956001
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay",9606,NA,NA,NA,NA,"D",956003
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 preincubated for 15 mins by CO2 hydration stopped-flow assay",9606,NA,NA,NA,NA,"D",956004
18694,"=","IC50",260,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2-mediated prostaglandin alpha production by enzyme immuno assay",9940,NA,NA,NA,NA,"D",956924
18694,">","IC50",1e+05,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1-mediated prostaglandin alpha production by enzyme immuno assay",9940,NA,NA,NA,NA,"D",956925
18694,"=","IC50",6000,"nM",22226,"B",NA,NA,"Inhibition of hyaluronan-induced CD44 antigen variant exon 6 activity in mouse APC10.1 cells expressing Has2 assessed as decrease in cell survival after 18 hrs by MTS assay",10090,NA,NA,NA,NA,"U",959012
18694,"=","IC50",17500,"nM",22226,"B",NA,NA,"Inhibition of hyaluronan-induced CD44 antigen variant exon 6 activity in human HCA-7 cells expressing Has2 assessed as decrease in cell survival after 18 hrs by MTS assay",9606,NA,NA,NA,NA,"U",959013
18694,"=","IC50",18300,"nM",22226,"B",NA,NA,"Inhibition of hyaluronan-induced CD44 antigen variant exon 6 activity in human HT-29 cells expressing Has2 assessed as decrease in cell survival after 18 hrs by MTS assay",9606,NA,NA,NA,NA,"U",959014
18694,"=","IC50",12530000,"nM",96,"B",NA,NA,"Inhibition of platelet COX1 in human whole blood assessed as inhibition of serum TXB2 production after 1 hr by radioimmunoassay",9606,NA,"Blood",NA,NA,"D",963754
18694,"=","IC50",390000,"nM",126,"B",NA,NA,"Inhibition of monocyte COX2 in human whole blood assessed as inhibition of LPS-induced plasma PGE2 production after 24 hrs by radioimmunoassay",9606,NA,"Blood",NA,NA,"D",963755
18694,"=","IC50",61,"nM",11112,"B",NA,NA,"Inhibition of COX2 in mouse J774 cells assessed as inhibition of LPS-induced PGE2 production by radioimmunoassay",10090,NA,NA,NA,NA,"D",963764
18694,"=","IC50",3840,"nM",10575,"B",NA,NA,"Inhibition of COX1 in mouse J774 cells using arachidonic acid as substrate assessed as inhibition of PGE2 production incubated for 15 mins prior to substrate addition measured after 30 mins by radioimmunoassay",10090,NA,NA,NA,NA,"D",963765
18694,">","IC50",1000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 by fluorescence assay",9940,NA,NA,NA,NA,"D",967831
18694,"=","IC50",20,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 by fluorescence assay",9606,NA,NA,NA,NA,"D",967832
18694,"=","IC50",48000,"nM",10612,"B",NA,NA,"Inhibition of PDK1-mediated Akt activation in human PC3 cells after 2 hrs by Western blotting analysis",9606,NA,NA,NA,NA,"D",971018
18694,"=","IC50",150,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 using arachidonic acid as substrate assessed as production of PGF2alpha preincubated for 10 mins followed by substrate addition measured after 2 mins by EIA in presence of stannous chloride",9940,NA,NA,NA,NA,"D",975623
18694,">","IC50",30000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 using arachidonic acid as substrate assessed as production of PGF2alpha preincubated for 10 mins followed by substrate addition measured after 2 mins by EIA in presence of stannous chloride",9940,NA,NA,NA,NA,"D",975624
18694,"=","Ki",2170,"nM",11060,"B",NA,NA,"Inhibition of human cytosolic carbonic anhydrase 7 preincubated for 15 mins by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",976157
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human cytosolic carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",976158
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human cytosolic carbonic anhydrase 1 preincubated for 15 mins by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",976159
18694,"=","Ki",18,"nM",12209,"B",NA,NA,"Inhibition of human membrane bound carbonic anhydrase 12 preincubated for 15 mins at room temperature followed by 72 hrs at 4 degC by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",982792
18694,"=","Ki",16,"nM",12952,"B",NA,NA,"Inhibition of human membrane bound carbonic anhydrase 9 preincubated for 15 mins at room temperature followed by 72 hrs at 4 degC by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",982793
18694,"=","Ki",2170,"nM",11060,"B",NA,NA,"Inhibition of human cytosolic carbonic anhydrase 7 preincubated for 15 mins at room temperature followed by 72 hrs at 4 degC by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",982794
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human cytosolic carbonic anhydrase 2 preincubated for 15 mins at room temperature followed by 72 hrs at 4 degC by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",982795
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human cytosolic carbonic anhydrase 1 preincubated for 15 mins at room temperature followed by 72 hrs at 4 degC by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",982796
442943,"=","IC50",250720,"nM",102878,"B",NA,NA,"Inhibition of Mycobacterium tuberculosis pantothenate synthetase",1773,NA,NA,NA,NA,"D",988132
18694,"=","Ki",705,"nM",22226,"B","In vitro",NA,"Inhibition of recombinant Leishmania donovani chagasi beta-carbonic anhydrase expressed in baculovirus infected insect Sf9 cells incubated for 15 mins prior to testing by stopped flow CO2 hydrase assay",44271,NA,NA,NA,NA,"U",991722
18694,"=","IC50",320,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 expressed in insect cell expression system using TMPD and arachidonic acid as substrate incubated for 1 min prior to substrate addition by spectrophotometry",9606,NA,NA,NA,NA,"D",1275064
18694,"=","IC50",25740,"nM",96,"B",NA,NA,"Inhibition of COX1 (unknown origin)",9606,NA,NA,NA,NA,"D",1275065
18694,"=","Ki",2170,"nM",11060,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1281628
18694,"=","IC50",15000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 using arachidonic acid as substrate incubated for 10 mins prior to substrate addition measured after 2 mins by spectrophotometry",9940,NA,NA,NA,NA,"D",1281694
18694,"=","IC50",40,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 using arachidonic acid as substrate incubated for 10 mins prior to substrate addition measured after 2 mins by spectrophotometry",9606,NA,NA,NA,NA,"D",1281695
18694,"=","IC50",57,"nM",126,"B",NA,NA,"Inhibition of COX-2 (unknown origin) by ELISA",9606,NA,NA,NA,NA,"D",1282187
18694,"=","IC50",22900,"nM",17047,"B",NA,NA,"Inhibition of ram seminal vesicle COX-1 assessed as conversion of arachidonic acid to PGH2",9940,NA,NA,NA,NA,"D",1282188
18694,"=","Ki",265,"nM",107983,"B",NA,NA,"Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay",67004,NA,NA,NA,NA,"D",1282543
18694,"=","Ki",169,"nM",22226,"B",NA,NA,"Inhibition of Porphyromonas gingivalis recombinant gamma-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay",837,NA,NA,NA,NA,"U",1282544
18694,"=","Ki",705,"nM",22226,"B",NA,NA,"Inhibition of Leishmania donovani chagasi recombinant beta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay",44271,NA,NA,NA,NA,"U",1282545
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1282546
18694,"=","Ki",140,"nM",22226,"B",NA,NA,"Inhibition of recombinant Methanosarcina thermophila gamma-CA CAM by stopped flow CO2 hydration assay",44271,NA,NA,NA,NA,"U",1282847
18694,"=","Ki",169,"nM",22226,"B",NA,NA,"Inhibition of Porphyromonas gingivalis gamma-carbonic anhydrase expressed in Escherichia coli preincubated for 15 mins by stopped flow CO2 hydration assay",837,NA,NA,NA,NA,"U",1282848
18694,"=","IC50",540,"nM",126,"B",NA,NA,"Inhibition of COX-2 in human whole blood assessed as prostaglandin E2 production by RIA",9606,NA,"Blood",NA,NA,"D",1284702
18694,"=","IC50",12470,"nM",96,"B",NA,NA,"Inhibition of COX-1 in human whole blood assessed as thromboxane B2 production by RIA",9606,NA,"Blood",NA,NA,"D",1284704
18694,"=","IC50",24300,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 using arachidonic acid as substrate by chemiluminescence assay",9940,NA,NA,NA,NA,"D",1286092
18694,"=","IC50",60,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 using arachidonic acid as substrate by chemiluminescence assay",9940,NA,NA,NA,NA,"D",1286093
485738,"=","EC50",15000,"nM",22226,"B",NA,NA,"Inhibition of influenza A virus RNA-dependent RNA polymerase expressed in HEK293 cells after 24 hrs by dual luciferase reporter gene assay",11320,NA,NA,NA,NA,"U",1286948
18694,"=","IC50",280,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 by peroxidase activity-based colorimetric assay",9940,NA,NA,NA,NA,"D",1288419
18694,"=","IC50",350,"nM",126,"B",NA,NA,"Inhibition of COX-2 in human whole blood assessed as PGE2 level in plasma after 5 mins by enzyme immunoassay",9606,NA,"Blood",NA,NA,"D",1289924
18694,"=","IC50",2600,"nM",96,"B",NA,NA,"Inhibition of COX-1 in human whole blood assessed as thromboxane B2 level in serum after 5 mins by enzyme immunoassay",9606,NA,"Blood",NA,NA,"D",1289925
18694,"=","Ki",18,"nM",12209,"B",NA,NA,"Inhibition of human transmembrane carbonic anhydrase 12 by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1291174
18694,"=","Ki",16,"nM",12952,"B",NA,NA,"Inhibition of human transmembrane carbonic anhydrase 9 by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1291175
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human cytosolic carbonic anhydrase 2 by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1291176
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human cytosolic carbonic anhydrase 1 by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1291177
18694,"=","IC50",40,"nM",126,"B",NA,NA,"Inhibition of human COX2 using arachidonic acid as substrate assessed as PGE2 formation incubated for 10 mins prior to substrate addition measured after 10 mins by ELISA",9606,NA,NA,NA,NA,"D",1294266
18694,"=","IC50",15000,"nM",96,"B",NA,NA,"Inhibition of human COX1 using arachidonic acid as substrate assessed as PGE2 formation incubated for 10 mins prior to substrate addition measured after 10 mins by ELISA",9606,NA,NA,NA,NA,"D",1294267
18694,"=","IC50",280,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 using arachidonic acid as substrate incubated for 10 mins prior to substrate addition measured after 2 mins by enzyme immunoassay",9606,NA,NA,NA,NA,"D",1294581
18694,">","IC50",50000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 using arachidonic acid as substrate incubated for 10 mins prior to substrate addition measured after 2 mins by enzyme immunoassay",9940,NA,NA,NA,NA,"D",1294582
23466,"=","Ki",0.52,"nM",11871,"B",NA,NA,"Time dependent inhibition of human recombinant MMP12 by SPR assay",9606,NA,NA,NA,NA,"D",1298985
23466,"=","Ki",3.8,"nM",11871,"B",NA,NA,"Inhibition of human recombinant MMP12 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 10 mins prior to substrate addition by spectrophotometry",9606,NA,NA,NA,NA,"D",1298987
485738,NA,"Potency",35481.3,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301608
23466,NA,"Potency",35481.3,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301608
442943,NA,"Potency",3548.1,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301608
23721,NA,"Potency",17782.8,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301608
23466,NA,"Potency",35481.3,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301608
160475,NA,"Potency",35481.3,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301608
442943,NA,"Potency",1995.3,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301608
87221,NA,"Potency",25118.9,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301608
442943,NA,"Potency",1258.9,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301866
23721,NA,"Potency",8912.5,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301866
87221,NA,"Potency",14125.4,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301866
3049,NA,"Potency",2511.9,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301866
160475,NA,"Potency",10000,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301866
485738,NA,"Potency",11220.2,"nM",22226,"B",NA,"confirmatory","PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ",NA,NA,NA,NA,NA,"U",1301866
17224,"=","Ki",0.732,"nM",22226,"B",NA,NA,"Inhibition of HIV1 protease using fluorogenic hexapeptide substrate (2-aminobenzoyl)Thr-Ile-Nle-(p-nitro)Phe-Gln-Arg by fluorimeter",11676,NA,NA,NA,NA,"U",1328821
485738,"=","IC50",65880,"nM",62,"B",NA,NA,"Inhibition of human topoisomerase 1 activity assessed as DNA triplex formation and presence of supercoiled DNA by microplate assay",9606,NA,NA,NA,NA,"D",1330828
568326,"=","IC50",1000,"nM",10368,"B",NA,NA,"Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay",9606,NA,NA,NA,NA,"D",1334961
18694,"=","IC50",2660,"nM",126,"B",NA,NA,"Inhibition of COX2 (unknown origin) by colorimetric method",9606,NA,NA,NA,NA,"D",1335154
18694,"=","IC50",117000,"nM",17047,"B",NA,NA,"Inhibition of purified ovine COX-1 by enzyme immunoassay",9940,NA,NA,NA,NA,"D",1337743
18694,"=","IC50",70,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX-2 by enzyme immunoassay",9606,NA,NA,NA,NA,"D",1337744
18694,">","IC50",30000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 using arachidonic acid as substrate assessed as conversion of PGH2 to PGF2alpha after 10 mins by EIA",9940,NA,NA,NA,NA,"D",1338899
18694,"=","IC50",220,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 using arachidonic acid as substrate assessed as conversion of PGH2 to PGF2alpha after 10 mins by EIA",9940,NA,NA,NA,NA,"D",1338900
18694,"=","IC50",8.7,"nM",11112,"B",NA,NA,"Inhibition of COX-2 in mouse RAW264.7 cells assessed as decrease in LPS-induced PGE2 production treated prior to LPS challenge by enzyme immunoassay",10090,NA,NA,NA,NA,"D",1338950
18694,">","IC50",1000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX-1 assessed as decrease in PGH2 production using arachidonic acid as substrate treated with enzyme for 10 mins prior to substrate challenge for 2 mins by enzyme immunoassay",9940,NA,NA,NA,NA,"D",1338951
18694,"=","IC50",72,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX-2 assessed as decrease in PGH2 production using arachidonic acid as substrate treated with enzyme for 10 mins prior to substrate challenge for 2 mins by enzyme immunoassay",9606,NA,NA,NA,NA,"D",1338952
18694,"=","IC50",20400,"nM",96,"B",NA,NA,"Inhibition of COX-1 (unknown origin)",9606,NA,NA,NA,NA,"D",1347549
18694,"=","IC50",270,"nM",126,"B",NA,NA,"Inhibition of COX-2 (unknown origin)",9606,NA,NA,NA,NA,"D",1347550
18694,">","IC50",1e+05,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 after 2 mins by EIA",9940,NA,NA,NA,NA,"D",1348630
18694,"=","IC50",280,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 after 2 mins by EIA",9606,NA,NA,NA,NA,"D",1348631
18694,"=","IC50",15000,"nM",12478,"B",NA,NA,"Inhibition of rat seminal vesicle COX-1 using arachidonic acid as substrate assessed as reduction of PGG2 to PGH2 incubated for 1 min prior to substrate addition measured after 25 secs by chromogenic assay",10116,NA,NA,NA,NA,"D",1349359
18694,"=","IC50",40,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX-2 expressed in insect cell system using arachidonic acid as substrate assessed as reduction of PGG2 to PGH2 incubated for 1 min prior to substrate addition measured after 25 secs by chromogenic assay",9606,NA,NA,NA,NA,"D",1349360
18694,">","IC50",30000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 using arachidonic acid as substrate preincubated for 10 mins before substrate addition measured after 5 mins by EIA",9940,NA,NA,NA,NA,"D",1349453
18694,"=","IC50",150,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 using arachidonic acid as substrate preincubated for 10 mins before substrate addition measured after 5 mins by EIA",9940,NA,NA,NA,NA,"D",1349454
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human carbonic anhydrase-1 by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1349989
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human carbonic anhydrase-2 by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1349990
18694,"=","Ki",990,"nM",22226,"B",NA,NA,"Inhibition of Legionella pneumophilia subsp. Pneumophila strain Philadelphia-1 carbonic anhydrase-1 assessed as CO2 hydrase activity by stopped-flow assay",272624,NA,NA,NA,NA,"U",1349992
18694,"=","Ki",421,"nM",22226,"B",NA,NA,"Inhibition of Legionella pneumophilia subsp. Pneumophila strain Philadelphia-1 carbonic anhydrase-2 assessed as CO2 hydrase activity by stopped-flow assay",272624,NA,NA,NA,NA,"U",1349993
18694,"=","IC50",40,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 peroxidase activity assessed as reduction of PGG2 to PGH2 by measuring oxidized TMPD level by colorimetric assay",9940,NA,NA,NA,NA,"D",1350482
18694,"=","IC50",14000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 peroxidase activity assessed as reduction of PGG2 to PGH2 by measuring oxidized TMPD level by colorimetric assay",9940,NA,NA,NA,NA,"D",1350483
485738,"=","EC50",24900,"nM",22226,"B",NA,NA,"Inhibition of Influenza A virus RdRP infected in human HEK293T cells after 24 hrs by dual luciferase reporter gene assay",11320,NA,NA,NA,NA,"U",1362816
18694,"=","IC50",27250,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 using arachidonic acid as substrate",9940,NA,NA,NA,NA,"D",1362991
18694,"=","IC50",290,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 using arachidonic acid as substrate",9606,NA,NA,NA,NA,"D",1362992
18694,"=","IC50",150,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 assessed as reduction in PGF2alpha formation incubated for 18 hrs by enzyme immunoassay",9940,NA,NA,NA,NA,"D",1433904
18694,"=","IC50",30000,"nM",17047,"B",NA,NA,"Inhibition of purified ovine COX1 pre-treated for 1 hr before 10-acetyl-3,7-dihydroxyphenoxazin substrate addition in absence of porcine liver esterase by fluorescence assay",9940,NA,NA,NA,NA,"D",1436065
18694,"=","IC50",50,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 pre-treated for 1 hr before 10-acetyl-3,7-dihydroxyphenoxazin substrate addition in absence of porcine liver esterase by fluorescence assay",9606,NA,NA,NA,NA,"D",1436067
18694,"=","IC50",32000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1",9940,NA,NA,NA,NA,"D",1436536
18694,"=","IC50",300,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2",9940,NA,NA,NA,NA,"D",1436537
17224,">","Ki",20000,"nM",22226,"B",NA,NA,"Inhibition of HTLV-1 protease",11908,NA,NA,NA,NA,"U",1446822
18694,"=","IC50",15000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX-1 assessed as decrease in prostaglandin production using arachidonic acid as substrate incubated with enzyme for 10 mins prior to substrate challenge by enzyme immunoassay",9940,NA,NA,NA,NA,"D",1447353
18694,"=","IC50",40,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX-2 assessed as decrease in prostaglandin production using arachidonic acid as substrate incubated with enzyme for 10 mins prior to substrate challenge by enzyme immunoassay",9606,NA,NA,NA,NA,"D",1447358
18694,">","IC50",50000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 assessed as reduction in PGH2 production using arachidonic acid substrate by enzyme immunoassay",9940,NA,NA,NA,NA,"D",1452419
18694,"=","IC50",280,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 assessed as reduction in PGH2 production using arachidonic acid substrate by enzyme immunoassay",9940,NA,NA,NA,NA,"D",1452420
18694,"=","IC50",15030,"nM",96,"B",NA,NA,"Inhibition of COX1 (unknown origin) by solid phase ELISA method",9606,NA,NA,NA,NA,"D",1455369
18694,"=","IC50",40,"nM",126,"B",NA,NA,"Inhibition of COX2 (unknown origin) by solid phase ELISA method",9606,NA,NA,NA,NA,"D",1455370
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant Carbonic anhydrase 1 compound preincubated for 15 mins by stopped flow CO2 hydrase assay method",9606,NA,NA,NA,NA,"D",1456832
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant Carbonic anhydrase 2 compound preincubated for 15 mins by stopped flow CO2 hydrase assay method",9606,NA,NA,NA,NA,"D",1456833
18694,"=","Ki",4150,"nM",22226,"B",NA,NA,"Inhibition of Porphyromonas gingivalis Beta-carbonic anhydrase compound preincubated for 15 mins by stopped flow CO2 hydrase assay method",837,NA,NA,NA,NA,"U",1456835
18694,"=","Ki",169,"nM",22226,"B",NA,NA,"Inhibition of Porphyromonas gingivalis Gamma-carbonic anhydrase compound preincubated for 15 mins by stopped flow CO2 hydrase assay method",837,NA,NA,NA,NA,"U",1456836
18694,">","IC50",50000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 assessed as reduction in PGH2-dervied PGF2alpha production using arachidonic acid substrate by enzyme immunoassay",9940,NA,NA,NA,NA,"D",1458891
18694,"=","IC50",280,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 assessed as reduction in PGH2-dervied PGF2alpha production using arachidonic acid substrate by enzyme immunoassay",9940,NA,NA,NA,NA,"D",1458892
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1461812
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1461813
18694,"=","Ki",217,"nM",22226,"B",NA,NA,"Inhibition of Plasmodium falciparum Eta-carbonic anhydrase pre-incubated for 15 mins before CO2 substrate addition by stopped-flow CO2 hydration assay",5833,NA,NA,NA,NA,"U",1461814
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant CA-1 after 15 mins by stopped-flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",1465099
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant CA-2 after 15 mins by stopped-flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",1465100
18694,"=","Ki",2170,"nM",11060,"B",NA,NA,"Inhibition of human recombinant CA-7 after 15 mins by stopped-flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",1465101
18694,"=","Ki",16,"nM",12952,"B",NA,NA,"Inhibition of human recombinant CA-9 after 15 mins by stopped-flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",1465102
18694,"=","Ki",18,"nM",12209,"B",NA,NA,"Inhibition of human recombinant CA-12 after 15 mins by stopped-flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",1465103
18694,"=","IC50",78400,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 using fluorometric substrate after 15 mins",9940,NA,NA,NA,NA,"D",1465326
18694,"=","IC50",19,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 using fluorometric substrate after 15 mins",9606,NA,NA,NA,NA,"D",1465327
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",1465408
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydrase assay",9606,NA,NA,NA,NA,"D",1465409
18694,"=","Ki",140,"nM",22226,"B",NA,NA,"Inhibition of recombinant Methanosarcina thermophila gamma-carbonic anhydrase by stopped flow CO2 hydrase assay",2210,NA,NA,NA,NA,"U",1465410
18694,"=","Ki",169,"nM",22226,"B",NA,NA,"Inhibition of recombinant Porphyromonas gingivalis gamma-carbonic anhydrase by stopped flow CO2 hydrase assay",837,NA,NA,NA,NA,"U",1465411
18694,"=","Ki",87.6,"nM",22226,"B",NA,NA,"Inhibition of recombinant Nostoc commune gamma-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydrase assay",1178,NA,NA,NA,NA,"U",1465412
18694,"=","Ki",50000,"nM",10193,"B",NA,NA,"Inhibition of human carbonic anhydrase 1 pre-incubated for 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1466705
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human carbonic anhydrase 2 pre-incubated for 15 mins by stopped-flow CO2 hydration assay",9606,NA,NA,NA,NA,"D",1466706
18694,"=","Ki",173,"nM",109570,"B",NA,NA,"Inhibition of Anopheles gambiae carbonic anhydrase pre-incubated for 15 mins by stopped-flow CO2 hydration assay",7165,NA,NA,NA,NA,"D",1466707
18694,">","IC50",1e+05,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 assessed as inhibition of PGF2alpha production from PGH2 preincubated for 5 mins before arachidonic acid addition measured after 2 mins by enzyme immunoassay",9940,NA,NA,NA,NA,"D",1467707
18694,"=","IC50",260,"nM",17100,"B",NA,NA,"Inhibition of ovine COX2 assessed as inhibition of PGF2alpha production from PGH2 preincubated for 5 mins before arachidonic acid addition measured after 2 mins by enzyme immunoassay",9940,NA,NA,NA,NA,"D",1467708
18694,"=","IC50",32600,"nM",96,"B",NA,NA,"Inhibition of human recombinant COX1 by ELISA",9606,NA,NA,NA,NA,"D",1468556
18694,"=","IC50",52,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 by ELISA",9606,NA,NA,NA,NA,"D",1468557
442943,"=","IC50",9000,"nM",101079,"B",NA,NA,"Inhibition of human DDR2 expressed in HEK293 cells assessed as reduction in collagen-1-induced DDR2 tyrosine phosphorylation pre-incubated for 30 mins by immunoblotting method",9606,NA,NA,NA,NA,"D",1474744
18694,"=","Ki",2425,"nM",22226,"B",NA,NA,"Inhibition of recombinant Streptococcus mutans UA159 beta-carbonic anhydrase expressed in Escherichia coli Arctic cells preincubated for 15 mins by stopped flow CO2 hydrase assay",210007,NA,NA,NA,NA,"U",1475817
18694,"=","IC50",81700,"nM",17047,"B",NA,NA,"Inhibition of ovine COX1 pre-incubated for 15 mins followed by addition of heme and fluorometric substrate and further incubated for 15 mins in presence of arachidonic acid by fluorescence based assay",9940,NA,NA,NA,NA,"D",1477170
18694,"=","IC50",16,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX2 pre-incubated for 15 mins followed by addition of heme and fluorometric substrate and further incubated for 15 mins in presence of arachidonic acid by fluorescence based assay",9606,NA,NA,NA,NA,"D",1477171
18694,"=","IC50",15000,"nM",17047,"B",NA,NA,"Inhibition of ovine COX-1 assessed as PGF2alpha formation using arachidonic acid as substrate pretreated with compound for 20 mins prior to substrate addition by spectrophotometric analysis",9940,NA,NA,NA,NA,"D",1495498
18694,"=","IC50",40,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX-2 assessed as PGF2 alpha formation using arachidonic acid as substrate pretreated with compound for 20 mins prior to substrate addition by spectrophotometric analysis",9606,NA,NA,NA,NA,"D",1495499
485738,"=","EC50",18000,"nM",22226,"B",NA,NA,"Inhibition of Influenza A virus (A/PR/8/34) RNA-dependent-RNA polymerase transfected in HEK293T cells after 24 hrs by renilla luciferase activity/minireplicon assay",211044,NA,NA,NA,NA,"U",1496010
18694,">","IC50",1e+05,"nM",17047,"B",NA,NA,"Inhibition of ovine COX-1 assessed as reduction of prostaglandin-G2 to prostaglandin-H2 and oxidation of 10-acetyl-3,7-dihydroxyphenoxazine to resorufin after 5 mins by fluorescence based assay",9940,NA,NA,NA,NA,"D",1508747
18694,"=","IC50",130,"nM",126,"B",NA,NA,"Inhibition of recombinant human COX-2 assessed as reduction of prostaglandin-G2 to prostaglandin-H2 and oxidation of 10-acetyl-3,7-dihydroxyphenoxazine to resorufin after 5 mins by fluorescence based assay",9606,NA,NA,NA,NA,"D",1508748
18694,"=","Ki",87.6,"nM",22226,"B",NA,NA,"Inhibition of Nostoc commune gamma carbonic anhydrase by CO2 hydration assay",1178,NA,NA,NA,NA,"U",1511552
18694,"=","Ki",761,"nM",22226,"B",NA,NA,"Inhibition of Pseudoalteromonas haloplanktis gamma carbonic anhydrase by CO2 hydration assay",228,NA,NA,NA,NA,"U",1511553
18694,"=","Ki",140,"nM",22226,"B",NA,NA,"Inhibition of Methanosarcina thermophila recombinant gamma carbonic anhydrase by stopped flow CO2 hydrase assay method",2210,NA,NA,NA,NA,"U",1511554
18694,"=","Ki",21,"nM",15,"B",NA,NA,"Inhibition of human recombinant carbonic anhydrase-2 by stopped flow CO2 hydrase assay method",9606,NA,NA,NA,NA,"D",1511555
18694,"=","IC50",78400,"nM",17047,"B",NA,NA,"Inhibition of ovine COX-1 using arachidonic acid after 15 mins by fluorescence based assay",9940,NA,NA,NA,NA,"D",1521283
18694,"=","IC50",19,"nM",126,"B",NA,NA,"Inhibition of human recombinant COX-2 using arachidonic acid after 15 mins by fluorescence based assay",9606,NA,NA,NA,NA,"D",1521284
18694,">","IC50",1e+05,"nM",17047,"B",NA,NA,"Inhibition of ovine COX-1 using arachidonic acid after 5 mins by colorimetric method",9940,NA,NA,NA,NA,"D",1522568
18694,"=","IC50",560,"nM",17100,"B",NA,NA,"Inhibition of ovine COX-2 using arachidonic acid after 5 mins by colorimetric method",9940,NA,NA,NA,NA,"D",1522569
18694,"=","IC50",48000,"nM",10612,"B","In vitro",NA,"BindingDB_Patents: In Vitro Kinase Assay. PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.",9606,NA,NA,NA,NA,"D",1527616
1295448,">","Ki",10000,"nM",100411,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TOPK",NA,NA,NA,NA,NA,"H",809114
1295448,">","Ki",7943.28,"nM",101464,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K4",NA,NA,NA,NA,NA,"H",809115
1295448,">","Ki",10000,"nM",100845,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA",NA,NA,NA,NA,NA,"H",809116
1295448,">","Ki",10000,"nM",101269,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KIAA1811",NA,NA,NA,NA,NA,"H",809119
1295448,">","Ki",6309.57,"nM",12090,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: DYRK1A",NA,NA,NA,NA,NA,"H",809121
1295448,"=","Ki",1000,"nM",100410,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL",NA,NA,NA,NA,NA,"H",809128
1295448,">","Ki",7943.28,"nM",10277,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK3",NA,NA,NA,NA,NA,"H",809133
1295448,">","Ki",7943.28,"nM",11629,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2",NA,NA,NA,NA,NA,"H",809134
1295448,">","Ki",7943.28,"nM",12724,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3",NA,NA,NA,NA,NA,"H",809138
1295448,">","Ki",7943.28,"nM",30014,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2",NA,NA,NA,NA,NA,"H",809139
1295448,">","Ki",7943.28,"nM",10216,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCZ",NA,NA,NA,NA,NA,"H",809142
1295448,"=","Ki",630.96,"nM",100412,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PLK3",NA,NA,NA,NA,NA,"H",809145
1295448,">","Ki",10000,"nM",10696,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AKT3",NA,NA,NA,NA,NA,"H",809147
1295448,"=","Ki",1258.93,"nM",11364,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1",NA,NA,NA,NA,NA,"H",809149
1295448,">","Ki",7943.28,"nM",12247,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCD",NA,NA,NA,NA,NA,"H",809151
1295448,"=","Ki",630.96,"nM",30003,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PLK4",NA,NA,NA,NA,NA,"H",809153
1295448,"=","Ki",6309.57,"nM",100415,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2",NA,NA,NA,NA,NA,"H",809155
1295448,">","Ki",6309.57,"nM",12944,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KB1",NA,NA,NA,NA,NA,"H",809156
1295448,">","Ki",6309.57,"nM",30002,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2G",NA,NA,NA,NA,NA,"H",809158
1295448,"=","Ki",1995.26,"nM",20015,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EEF2K",NA,NA,NA,NA,NA,"H",809159
1295448,">","Ki",10000,"nM",10885,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCN",NA,NA,NA,NA,NA,"H",809163
1295448,">","Ki",7943.28,"nM",11149,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ROCK2",NA,NA,NA,NA,NA,"H",809170
1295448,">","Ki",7943.28,"nM",11678,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2",NA,NA,NA,NA,NA,"H",809171
1295448,"=","Ki",7943.28,"nM",10839,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM1",NA,NA,NA,NA,NA,"H",809174
1295448,"=","Ki",5011.87,"nM",11082,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2",NA,NA,NA,NA,NA,"H",809177
1295448,">","Ki",6309.57,"nM",10044,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK2A1",NA,NA,NA,NA,NA,"H",809183
1295448,">","Ki",10000,"nM",30025,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PAK1",NA,NA,NA,NA,NA,"H",809185
1295448,">","Ki",6309.57,"nM",11622,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D",NA,NA,NA,NA,NA,"H",809186
1295448,">","Ki",7943.28,"nM",10695,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AKT2",NA,NA,NA,NA,NA,"H",809187
1295448,">","Ki",6309.57,"nM",11720,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1A1",NA,NA,NA,NA,NA,"H",809189
1295448,">","Ki",7943.28,"nM",10842,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PKN2",NA,NA,NA,NA,NA,"H",809196
1295448,">","Ki",10000,"nM",30018,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LIMK1",NA,NA,NA,NA,NA,"H",809197
1295448,"=","Ki",3981.07,"nM",101131,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TAO1",NA,NA,NA,NA,NA,"H",809198
1295448,">","Ki",6309.57,"nM",100140,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3",NA,NA,NA,NA,NA,"H",809204
1295448,">","Ki",7943.28,"nM",11081,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK13",NA,NA,NA,NA,NA,"H",809209
1295448,"=","Ki",3162.28,"nM",20007,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ZAK",NA,NA,NA,NA,NA,"H",809211
1295448,">","Ki",7943.28,"nM",100855,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM3",NA,NA,NA,NA,NA,"H",809212
1295448,">","Ki",7943.28,"nM",10880,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCG",NA,NA,NA,NA,NA,"H",809215
1295448,"=","Ki",2511.89,"nM",11017,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A",NA,NA,NA,NA,NA,"H",809219
1295448,"=","Ki",1995.26,"nM",100947,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2",NA,NA,NA,NA,NA,"H",809220
1295448,">","Ki",6309.57,"nM",100851,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: DYRK3",NA,NA,NA,NA,NA,"H",809221
1295448,">","Ki",10000,"nM",100834,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK3",NA,NA,NA,NA,NA,"H",809229
1295448,">","Ki",7943.28,"nM",12967,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK1",NA,NA,NA,NA,NA,"H",809230
1295448,">","Ki",7943.28,"nM",10368,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D",NA,NA,NA,NA,NA,"H",809231
1295448,"=","Ki",3162.28,"nM",30037,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2",NA,NA,NA,NA,NA,"H",809234
1295448,">","Ki",7943.28,"nM",10396,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2B",NA,NA,NA,NA,NA,"H",809235
1295448,">","Ki",7943.28,"nM",10980,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR",NA,NA,NA,NA,NA,"H",809236
1295448,">","Ki",10000,"nM",12947,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK5",NA,NA,NA,NA,NA,"H",809238
1295448,">","Ki",10000,"nM",101557,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SGK",NA,NA,NA,NA,NA,"H",809241
1295448,"=","Ki",3162.28,"nM",101220,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MINK",NA,NA,NA,NA,NA,"H",809243
1295448,">","Ki",7943.28,"nM",103042,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: DYRK4",NA,NA,NA,NA,NA,"H",809245
1295448,"=","Ki",3162.28,"nM",19623,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: IRAK1",NA,NA,NA,NA,NA,"H",809250
1295448,"=","Ki",630.96,"nM",10781,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12",NA,NA,NA,NA,NA,"H",809255
1295448,">","Ki",10000,"nM",19639,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: IRAK4",NA,NA,NA,NA,NA,"H",809256
1295448,">","Ki",7943.28,"nM",12666,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AKT1",NA,NA,NA,NA,NA,"H",809257
1295448,"=","Ki",1995.26,"nM",30049,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K5",NA,NA,NA,NA,NA,"H",809258
1295448,">","Ki",6309.57,"nM",11752,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4",NA,NA,NA,NA,NA,"H",809260
1295448,">","Ki",10000,"nM",10811,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ROCK1",NA,NA,NA,NA,NA,"H",809262
1295448,">","Ki",6309.57,"nM",10970,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK1",NA,NA,NA,NA,NA,"H",809264
1295448,"=","Ki",2511.89,"nM",103106,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HIPK4",NA,NA,NA,NA,NA,"H",809266
1295448,">","Ki",7943.28,"nM",12071,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC2",NA,NA,NA,NA,NA,"H",809267
1295448,">","Ki",10000,"nM",101281,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: DCAMKL1",NA,NA,NA,NA,NA,"H",809270
1295448,">","Ki",10000,"nM",30017,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: NEK2",NA,NA,NA,NA,NA,"H",809271
1295448,"=","Ki",3981.07,"nM",30035,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SLK",NA,NA,NA,NA,NA,"H",809275
1295448,"=","Ki",3162.28,"nM",10907,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PLK1",NA,NA,NA,NA,NA,"H",809277
1295448,"=","Ki",1258.93,"nM",10197,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B",NA,NA,NA,NA,NA,"H",809278
1295448,"=","Ki",1258.93,"nM",30001,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2",NA,NA,NA,NA,NA,"H",809282
1295448,">","Ki",7943.28,"nM",11969,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKACA",NA,NA,NA,NA,NA,"H",809283
1295448,">","Ki",6309.57,"nM",12983,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK12",NA,NA,NA,NA,NA,"H",809284
1295448,">","Ki",6309.57,"nM",30036,"F",NA,"other","PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK4",NA,NA,NA,NA,NA,"H",809285
